1
|
Verhey LH, Kulkarni AV, Reeder RW, Riva-Cambrin J, Jensen H, Pollack IF, Rocque BG, Tamber MS, McDonald PJ, Krieger MD, Pindrik JA, Hauptman JS, Browd SR, Whitehead WE, Jackson EM, Wellons JC, Hankinson TC, Chu J, Limbrick DD, Strahle JM, Kestle JRW. A re-evaluation of the Endoscopic Third Ventriculostomy Success Score: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2024; 33:417-427. [PMID: 38335514 DOI: 10.3171/2023.12.peds23401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Accepted: 12/06/2023] [Indexed: 02/12/2024]
Abstract
OBJECTIVE The Hydrocephalus Clinical Research Network (HCRN) conducted a prospective study 1) to determine if a new, better-performing version of the Endoscopic Third Ventriculostomy Success Score (ETVSS) could be developed, 2) to explore the performance characteristics of the original ETVSS in a modern endoscopic third ventriculostomy (ETV) cohort, and 3) to determine if the addition of radiological variables to the ETVSS improved its predictive abilities. METHODS From April 2008 to August 2019, children (corrected age ≤ 17.5 years) who underwent a first-time ETV for hydrocephalus were included in a prospective multicenter HCRN study. All children had at least 6 months of clinical follow-up and were followed since the index ETV in the HCRN Core Data Registry. Children who underwent choroid plexus cauterization were excluded. Outcome (ETV success) was defined as the lack of ETV failure within 6 months of the index procedure. Kaplan-Meier curves were constructed to evaluate time-dependent variables. Multivariable binary logistic models were built to evaluate predictors of ETV success. Model performance was evaluated with Hosmer-Lemeshow and Harrell's C statistics. RESULTS Seven hundred sixty-one children underwent a first-time ETV. The rate of 6-month ETV success was 76%. The Hosmer-Lemeshow and Harrell's C statistics of the logistic model containing more granular age and etiology categorizations did not differ significantly from a model containing the ETVSS categories. In children ≥ 12 months of age with ETVSSs of 50 or 60, the original ETVSS underestimated success, but this analysis was limited by a small sample size. Fronto-occipital horn ratio (p = 0.37), maximum width of the third ventricle (p = 0.39), and downward concavity of the floor of the third ventricle (p = 0.63) did not predict ETV success. A possible association between the degree of prepontine adhesions on preoperative MRI and ETV success was detected, but this did not reach statistical significance. CONCLUSIONS This modern, multicenter study of ETV success shows that the original ETVSS continues to demonstrate good predictive ability, which was not substantially improved with a new success score. There might be an association between preoperative prepontine adhesions and ETV success, and this needs to be evaluated in a future large prospective study.
Collapse
Affiliation(s)
- Leonard H Verhey
- 1Division of Neurosurgery, Department of Clinical Neurosciences, Spectrum Health, Michigan State University, Grand Rapids, Michigan
| | - Abhaya V Kulkarni
- 2Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Ron W Reeder
- 3Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Jay Riva-Cambrin
- 4Division of Neurosurgery, Alberta Children's Hospital, University of Calgary, Alberta, Canada
| | - Hailey Jensen
- 3Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Ian F Pollack
- 5Department of Neurosurgery, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pennsylvania
| | - Brandon G Rocque
- 6Department of Neurosurgery, Children's of Alabama, University of Alabama, Birmingham, Alabama
| | - Mandeep S Tamber
- 7Division of Neurosurgery, UBC Department of Surgery, BC Children's Hospital, Vancouver, British Columbia, Canada
| | - Patrick J McDonald
- 8Section of Neurosurgery, Department of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Mark D Krieger
- 9Department of Neurosurgery, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, California
| | - Jonathan A Pindrik
- 10Division of Pediatric Neurosurgery, Nationwide Children's Hospital, Department of Neurological Surgery, The Ohio State University College of Medicine, Columbus, Ohio
| | - Jason S Hauptman
- 11Department of Neurological Surgery, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington
| | - Samuel R Browd
- 11Department of Neurological Surgery, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington
| | - William E Whitehead
- 12Department of Neurosurgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas
| | - Eric M Jackson
- 13Department of Neurosurgery, Johns Hopkins Medicine, Baltimore, Maryland
| | - John C Wellons
- 14Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Todd C Hankinson
- 15Department of Neurosurgery, Children's Hospital Colorado, University of Colorado, Aurora, Colorado
| | - Jason Chu
- 9Department of Neurosurgery, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, California
| | - David D Limbrick
- 16Department of Neurosurgery, St. Louis Children's Hospital, Washington University School of Medicine in St. Louis, Missouri; and
| | - Jennifer M Strahle
- 16Department of Neurosurgery, St. Louis Children's Hospital, Washington University School of Medicine in St. Louis, Missouri; and
| | - John R W Kestle
- 17Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| |
Collapse
|
2
|
Browd SR, Park C, Donoho DA. Potential Applications of Artificial Intelligence and Machine Learning in Spine Surgery Across the Continuum of Care. Int J Spine Surg 2023:8507. [PMID: 37291063 DOI: 10.14444/8507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/10/2023] Open
Abstract
The worlds of spinal surgery and computational science are intersecting at the nexus of the operating room and across the continuum of patient care. As medicine moves toward digitizing all aspects of a patient's care, immense amounts of patient data generated and aggregated across surgeons, procedures, and institutions will enable previously inaccessible computationally driven insights. These early insights from artificial intelligence (AI) and machine learning (ML)-enabled technologies are beginning to transform medicine and surgery. The complex pathologies facing spine surgeons and their patients require integrative, multimodal, data-driven management strategies. As these data and the technological tools to computationally process them become increasingly available to spine surgeons, AI and ML methods will inform patient selection, preoperatively risk-stratify patients based on myriad factors, and inform interoperative surgical decisions. Once these tools enter early clinical practice, their use creates a virtual flywheel whereby the use of these tools generates additional data that further accelerate the evolution of computational "knowledge" systems. At this digital crossroads, interested and motivated surgeons have an opportunity to understand these technologies, guide their application toward optimal care, and advocate for opportunities where these powerful new tools can deliver step changes in efficiency, accuracy, and intelligence. In the present article, we review the nomenclature and basics of AI and ML and highlight the current and future applications of these technologies across the care continuum of spinal surgery.
Collapse
Affiliation(s)
- Samuel R Browd
- Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Christine Park
- Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Daniel A Donoho
- Division of Neurological Surgery, Center for Neuroscience and Behavior, Children's National Hospital, Washington, DC, USA
| |
Collapse
|
3
|
Bollo RJ, Gross PH, Rocque BG, Browd SR, Raskin JS, Leonard JR, Albarqawi L, Bailes AF. A multicenter initiative to reduce intrathecal baclofen pump surgical site infection: a Cerebral Palsy Research Network quality improvement project. J Neurosurg Pediatr 2023; 31:444-452. [PMID: 36840731 DOI: 10.3171/2023.1.peds22368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Accepted: 01/17/2023] [Indexed: 02/26/2023]
Abstract
OBJECTIVE Intrathecal baclofen (ITB) therapy is an effective treatment for spasticity and dystonia in children with cerebral palsy (CP). However, ITB pump surgery is associated with one of the highest rates of surgical site infection (SSI) in medicine, leading to significant morbidity and expense. Surgical protocols have reduced the rate of SSI in children with other CNS implants, and single-center protocols have been effective in ITB surgery in pediatrics. The authors describe the first multicenter quality improvement (QI)-driven standardized protocol for ITB pump surgery in children with CP across the Cerebral Palsy Research Network (CPRN), implemented with the aim of reducing ITB-associated SSI. METHODS SSI was defined as a culture-positive infection, ITB pump system removal for suspected infection, or wound dehiscence with exposed hardware. Each center reported historical infection rates for at least 3 years before initiating the SSI protocol (preintervention phase). After initiation of a 13-step surgical protocol, a consecutive series of 130 patients undergoing 149 surgical procedures for ITB at four CPRN tertiary pediatric neurosurgery centers were prospectively enrolled at surgery during a 2-year study period (intervention phase). QI methodology was used, including development of a key driver diagram and tracking performance using run and control charts. The primary process measure goal was documented compliance with 80% of the protocol steps, and the primary outcome measure goal was a 20% reduction in 90-day infection rate. Patient characteristics were collected from the CPRN Research Electronic Data Capture registry, including age at surgery, BMI, Gross Motor Function Classification System level, and pattern of spasticity. RESULTS The aggregated preintervention 90-day ITB SSI rate was 4.9% (223 procedures) between 2014 and 2017. During the intervention phase, 136 of 149 ITB surgeries performed met inclusion criteria for analysis. The mean documented compliance rate with protocol steps was 75%, and the 90-day infection rate was 4.4%, with an average of 42 days from index surgery to infection. CONCLUSIONS This is the first multicenter QI initiative designed to reduce SSI in ITB surgery in children with CP. Ongoing enrollment and expansion of the protocol to other CPRN centers will facilitate identification of patient- and procedure-specific risk factors for SSI, and iterative plan-do-study-act cycles incorporating these data will further decrease the risk of SSI for ITB surgery in children.
Collapse
Affiliation(s)
- Robert J Bollo
- 1Department of Neurosurgery, Division of Pediatric Neurosurgery, Primary Children's Hospital, University of Utah, Salt Lake City, Utah
| | - Paul H Gross
- 2Cerebral Palsy Research Network, Greensville, South Carolina
| | - Brandon G Rocque
- 3Department of Neurosurgery, Division of Pediatric Neurosurgery, Children's Hospital of Alabama, University of Alabama School of Medicine, Birmingham, Alabama
| | - Samuel R Browd
- 4Department of Neurosurgery, Division of Pediatric Neurosurgery, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington
| | - Jeffrey S Raskin
- 5Department of Neurosurgery, Division of Pediatric Neurosurgery, Riley Children's Hospital, University of Indiana School of Medicine, Indianapolis, Indiana
| | - Jeffrey R Leonard
- 6Department of Neurosurgery, Division of Pediatric Neurosurgery, Nationwide Children's Hospital, The Ohio State College of Medicine, The Ohio State University, Columbus, Ohio
| | - Lama Albarqawi
- 7Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, Utah
| | - Amy F Bailes
- 8Division of Occupational Therapy and Physical Therapy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and
- 9Department of Rehabilitation Exercise and Nutrition Sciences, University of Cincinnati School of Medicine, Cincinnati, Ohio
| |
Collapse
|
4
|
CreveCoeur TS, Alexiades NG, Bonfield CM, Brockmeyer DL, Browd SR, Chu J, Figaji AA, Groves ML, Hankinson TC, Harter DH, Hwang SW, Jea A, Kernie SG, Leonard JR, Martin JE, Oetgen ME, Powers AK, Rozzelle CJ, Skaggs DL, Strahle JM, Wellons JC, Vitale MG, Anderson RCE. Building consensus for the medical management of children with moderate and severe acute spinal cord injury: a modified Delphi study. J Neurosurg Spine 2023:1-14. [PMID: 36933257 DOI: 10.3171/2023.1.spine221188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Accepted: 01/31/2023] [Indexed: 03/19/2023]
Abstract
OBJECTIVE The focus of this modified Delphi study was to investigate and build consensus regarding the medical management of children with moderate and severe acute spinal cord injury (SCI) during their initial inpatient hospitalization. This impetus for the study was based on the AANS/CNS guidelines for pediatric SCI published in 2013, which indicated that there was no consensus provided in the literature describing the medical management of pediatric patients with SCIs. METHODS An international, multidisciplinary group of 19 physicians, including pediatric neurosurgeons, orthopedic surgeons, and intensivists, were asked to participate. The authors chose to include both complete and incomplete injuries with traumatic as well as iatrogenic etiologies (e.g., spinal deformity surgery, spinal traction, intradural spinal surgery, etc.) due to the overall low incidence of pediatric SCI, potentially similar pathophysiology, and scarce literature exploring whether different etiologies of SCI should be managed differently. An initial survey of current practices was administered, and based on the responses, a follow-up survey of potential consensus statements was distributed. Consensus was defined as ≥ 80% of participants reaching agreement on a 4-point Likert scale (strongly agree, agree, disagree, strongly disagree). A final meeting was held virtually to generate final consensus statements. RESULTS Following the final Delphi round, 35 statements reached consensus after modification and consolidation of previous statements. Statements were categorized into the following eight sections: inpatient care unit, spinal immobilization, pharmacological management, cardiopulmonary management, venous thromboembolism prophylaxis, genitourinary management, gastrointestinal/nutritional management, and pressure ulcer prophylaxis. All participants stated that they would be willing or somewhat willing to change their practices based on consensus guidelines. CONCLUSIONS General management strategies were similar for both iatrogenic (e.g., spinal deformity, traction, etc.) and traumatic SCIs. Steroids were recommended only for injury after intradural surgery, not after acute traumatic or iatrogenic extradural surgery. Consensus was reached that mean arterial pressure ranges are preferred for blood pressure targets following SCI, with goals between 80 and 90 mm Hg for children at least 6 years of age. Further multicenter study of steroid use following acute neuromonitoring changes was recommended.
Collapse
Affiliation(s)
| | - Nikita G Alexiades
- 2Department of Neurological Surgery, University of Arizona-Phoenix, Arizona
| | | | - Douglas L Brockmeyer
- 4Department of Pediatric Neurosurgery, Primary Children's Hospital, University of Utah, Salt Lake City, Utah
| | - Samuel R Browd
- 5Department of Neurosurgery, University of Washington/Seattle Children's Hospital, Seattle, Washington
| | - Jason Chu
- 6Department of Neurosurgery, Children's Hospital of Los Angeles, California
| | - Anthony A Figaji
- 7Department of Neurosurgery, University of Cape Town, Red Cross War Memorial Children's Hospital, Cape Town, South Africa
| | - Mari L Groves
- 8Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Todd C Hankinson
- 9Department of Pediatric Neurosurgery, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - David H Harter
- 10Department of Neurosurgery, New York University, New York, New York
| | - Steven W Hwang
- 11Shriners Hospital for Children, Philadelphia, Pennsylvania
| | - Andrew Jea
- 12Department of Neurological Surgery, University of Oklahoma, Oklahoma City, Oklahoma
| | - Steven G Kernie
- 13Department of Pediatrics, Columbia University, New York, New York
| | - Jeffrey R Leonard
- 14Department of Neurosurgery, Nationwide Children's Hospital, Columbus, Ohio
| | - Jonathan E Martin
- 15Department of Pediatric Neurosurgery, Connecticut Children's Hospital, Hartford, Connecticut
| | - Matthew E Oetgen
- 16Department of Orthopedic Surgery, Children's National Hospital, Washington, DC
| | - Alexander K Powers
- 17Department of Neurosurgery, Wake Forest University, Winston-Salem, North Carolina
| | - Curtis J Rozzelle
- 18Department of Pediatric Neurosurgery, University of Alabama, Birmingham, Alabama
| | - David L Skaggs
- 19Department of Orthopaedic Surgery, Cedars-Sinai Medical Center, Los Angeles, California; and
| | - Jennifer M Strahle
- 20Department of Neurosurgery, Washington University in St. Louis, Missouri
| | - John C Wellons
- 3Department of Neurological Surgery, Vanderbilt University, Nashville, Tennessee
| | - Michael G Vitale
- 21Orthopedic Surgery, Columbia University Medical Center, New York, New York
| | | |
Collapse
|
5
|
Vitanza NA, Ronsley R, Choe M, Henson C, Breedt M, Barrios-Anderson A, Wein A, Brown C, Beebe A, Kong A, Kirkey D, Lee BM, Leary SES, Crotty EE, Hoeppner C, Holtzclaw S, Wilson AL, Gustafson JA, Foster JB, Iliff JJ, Goldstein HE, Browd SR, Lee A, Ojemann JG, Pinto N, Gust J, Gardner RA, Jensen MC, Hauptman JS, Park JR. Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety. Neoplasia 2023; 36:100870. [PMID: 36599192 PMCID: PMC9823206 DOI: 10.1016/j.neo.2022.100870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Revised: 12/12/2022] [Accepted: 12/21/2022] [Indexed: 01/04/2023]
Abstract
Central nervous system (CNS) tumors are the most common solid malignancy in the pediatric population. Based on adoptive cellular therapy's clinical success against childhood leukemia and the preclinical efficacy against pediatric CNS tumors, chimeric antigen receptor (CAR) T cells offer hope of improving outcomes for recurrent tumors and universally fatal diseases such as diffuse intrinsic pontine glioma (DIPG). However, a major obstacle for tumors of the brain and spine is ineffective T cell chemotaxis to disease sites. Locoregional CAR T cell delivery via infusion through an intracranial catheter is currently under study in multiple early phase clinical trials. Here, we describe the Seattle Children's single-institution experience including the multidisciplinary process for the preparation of successful, repetitive intracranial T cell infusion for children and the catheter-related safety of our 307 intracranial CAR T cell doses.
Collapse
Affiliation(s)
- Nicholas A Vitanza
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
| | - Rebecca Ronsley
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Michelle Choe
- Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Casey Henson
- Division of Neurosurgery, Seattle Children's Hospital & Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Mandy Breedt
- Division of Neurosurgery, Seattle Children's Hospital & Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Adriel Barrios-Anderson
- Division of Neurosurgery, Seattle Children's Hospital & Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Amy Wein
- Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA
| | - Christopher Brown
- Seattle Children's Therapeutics, Seattle, WA, USA; Therapeutic Cell Production Core, Seattle Children's Research Institute, Seattle, WA, USA
| | - Adam Beebe
- Seattle Children's Therapeutics, Seattle, WA, USA; Therapeutic Cell Production Core, Seattle Children's Research Institute, Seattle, WA, USA
| | - Ada Kong
- Department of Pharmacy, Seattle Children's Hospital, Seattle, WA, USA
| | - Danielle Kirkey
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Brittany M Lee
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA
| | - Sarah E S Leary
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Erin E Crotty
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Corrine Hoeppner
- Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA
| | - Susan Holtzclaw
- Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA
| | | | | | - Jessica B Foster
- Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
| | - Jeffrey J Iliff
- VISN 20 Mental Illness Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, USA; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA; Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, WA, USA
| | - Hannah E Goldstein
- Division of Neurosurgery, Seattle Children's Hospital & Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Samuel R Browd
- Division of Neurosurgery, Seattle Children's Hospital & Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Amy Lee
- Division of Neurosurgery, Seattle Children's Hospital & Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Jeffrey G Ojemann
- Division of Neurosurgery, Seattle Children's Hospital & Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Navin Pinto
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA
| | - Juliane Gust
- Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, WA, USA; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA
| | - Rebecca A Gardner
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA; Seattle Children's Therapeutics, Seattle, WA, USA
| | | | - Jason S Hauptman
- Division of Neurosurgery, Seattle Children's Hospital & Department of Neurological Surgery, University of Washington, Seattle, WA, USA
| | - Julie R Park
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Seattle Children's Therapeutics, Seattle, WA, USA
| |
Collapse
|
6
|
Vitanza NA, Wilson AL, Huang W, Seidel K, Brown C, Gustafson JA, Yokoyama JK, Johnson AJ, Baxter BA, Koning RW, Reid AN, Meechan M, Biery MC, Myers C, Rawlings-Rhea SD, Albert CM, Browd SR, Hauptman JS, Lee A, Ojemann JG, Berens ME, Dun MD, Foster JB, Crotty EE, Leary SE, Cole BL, Perez FA, Wright JN, Orentas RJ, Chour T, Newell EW, Whiteaker JR, Zhao L, Paulovich AG, Pinto N, Gust J, Gardner RA, Jensen MC, Park JR. Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety. Cancer Discov 2023; 13:114-131. [PMID: 36259971 PMCID: PMC9827115 DOI: 10.1158/2159-8290.cd-22-0750] [Citation(s) in RCA: 58] [Impact Index Per Article: 58.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 09/13/2022] [Accepted: 10/13/2022] [Indexed: 01/16/2023]
Abstract
Diffuse intrinsic pontine glioma (DIPG) remains a fatal brainstem tumor demanding innovative therapies. As B7-H3 (CD276) is expressed on central nervous system (CNS) tumors, we designed B7-H3-specific chimeric antigen receptor (CAR) T cells, confirmed their preclinical efficacy, and opened BrainChild-03 (NCT04185038), a first-in-human phase I trial administering repeated locoregional B7-H3 CAR T cells to children with recurrent/refractory CNS tumors and DIPG. Here, we report the results of the first three evaluable patients with DIPG (including two who enrolled after progression), who received 40 infusions with no dose-limiting toxicities. One patient had sustained clinical and radiographic improvement through 12 months on study. Patients exhibited correlative evidence of local immune activation and persistent cerebrospinal fluid (CSF) B7-H3 CAR T cells. Targeted mass spectrometry of CSF biospecimens revealed modulation of B7-H3 and critical immune analytes (CD14, CD163, CSF-1, CXCL13, and VCAM-1). Our data suggest the feasibility of repeated intracranial B7-H3 CAR T-cell dosing and that intracranial delivery may induce local immune activation. SIGNIFICANCE This is the first report of repeatedly dosed intracranial B7-H3 CAR T cells for patients with DIPG and includes preliminary tolerability, the detection of CAR T cells in the CSF, CSF cytokine elevations supporting locoregional immune activation, and the feasibility of serial mass spectrometry from both serum and CSF. This article is highlighted in the In This Issue feature, p. 1.
Collapse
Affiliation(s)
- Nicholas A. Vitanza
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington.,Corresponding Author: Nicholas A. Vitanza, Seattle Children's Research Institute, M/S JMB-8, 1900 9th Avenue, Seattle, WA 98101. Phone: 206-884-4084; E-mail:
| | | | - Wenjun Huang
- Seattle Children's Therapeutics, Seattle, Washington
| | - Kristy Seidel
- Seattle Children's Therapeutics, Seattle, Washington
| | - Christopher Brown
- Seattle Children's Therapeutics, Seattle, Washington.,Therapeutic Cell Production Core, Seattle Children's Research Institute, Seattle, Washington
| | | | | | | | | | | | | | - Michael Meechan
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington
| | - Matthew C. Biery
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington
| | - Carrie Myers
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington
| | | | - Catherine M. Albert
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington
| | - Samuel R. Browd
- Division of Neurosurgery, Seattle Children's Hospital and Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Jason S. Hauptman
- Division of Neurosurgery, Seattle Children's Hospital and Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Amy Lee
- Division of Neurosurgery, Seattle Children's Hospital and Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Jeffrey G. Ojemann
- Division of Neurosurgery, Seattle Children's Hospital and Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Michael E. Berens
- Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona
| | - Matthew D. Dun
- School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, Callaghan, Australia.,Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia
| | - Jessica B. Foster
- Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.,Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
| | - Erin E. Crotty
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington
| | - Sarah E.S. Leary
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington
| | - Bonnie L. Cole
- Department of Laboratories, Seattle Children's Hospital, Seattle, Washington.,Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington
| | - Francisco A. Perez
- Department of Radiology, Seattle Children's Hospital, Seattle, Washington
| | - Jason N. Wright
- Department of Radiology, Seattle Children's Hospital, Seattle, Washington
| | - Rimas J. Orentas
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington
| | - Tony Chour
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington.,Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | - Evan W. Newell
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington.,Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington
| | | | - Lei Zhao
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington
| | - Amanda G. Paulovich
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington
| | - Navin Pinto
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington
| | - Juliane Gust
- Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington.,Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, Washington
| | - Rebecca A. Gardner
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington.,Seattle Children's Therapeutics, Seattle, Washington
| | | | - Julie R. Park
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington.,Seattle Children's Therapeutics, Seattle, Washington
| |
Collapse
|
7
|
Hersh DS, Martin JE, Bristol RE, Browd SR, Grant G, Gupta N, Hankinson TC, Jackson EM, Kestle JRW, Krieger MD, Kulkarni AV, Madura CJ, Pindrik J, Pollack IF, Raskin JS, Riva-Cambrin J, Rozzelle CJ, Smith JL, Wellons JC. Hydrocephalus surveillance following CSF diversion: a modified Delphi study. J Neurosurg Pediatr 2022; 30:1-11. [PMID: 35901763 DOI: 10.3171/2022.5.peds22116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/02/2022] [Accepted: 05/16/2022] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Long-term follow-up is often recommended for patients with hydrocephalus, but the frequency of clinical follow-up, timing and modality of imaging, and duration of surveillance have not been clearly defined. Here, the authors used the modified Delphi method to identify areas of consensus regarding the modality, frequency, and duration of hydrocephalus surveillance following surgical treatment. METHODS Pediatric neurosurgeons serving as institutional liaisons to the Hydrocephalus Clinical Research Network (HCRN), or its implementation/quality improvement arm (HCRNq), were invited to participate in this modified Delphi study. Thirty-seven consensus statements were generated and distributed via an anonymous electronic survey, with responses structured as a 4-point Likert scale (strongly agree, agree, disagree, strongly disagree). A subsequent, virtual meeting offered the opportunity for open discussion and modification of the statements in an effort to reach consensus (defined as ≥ 80% agreement or disagreement). RESULTS Nineteen pediatric neurosurgeons participated in the first round, after which 15 statements reached consensus. During the second round, 14 participants met virtually for review and discussion. Some statements were modified and 2 statements were combined, resulting in a total of 36 statements. At the conclusion of the session, consensus was achieved for 17 statements regarding the following: 1) the role of standardization; 2) preferred imaging modalities; 3) postoperative follow-up after shunt surgery (subdivided into immediate postoperative imaging, delayed postoperative imaging, routine clinical surveillance, and routine radiological surveillance); and 4) postoperative follow-up after an endoscopic third ventriculostomy. Consensus could not be achieved for 19 statements. CONCLUSIONS Using the modified Delphi method, 17 consensus statements were developed with respect to both clinical and radiological follow-up after a shunt or endoscopic third ventriculostomy. The frequency, modality, and duration of surveillance were addressed, highlighting areas in which no clear data exist to guide clinical practice. Although further studies are needed to evaluate the clinical utility and cost-effectiveness of hydrocephalus surveillance, the current study provides a framework to guide future efforts to develop standardized clinical protocols for the postoperative surveillance of patients with hydrocephalus. Ultimately, the standardization of hydrocephalus surveillance has the potential to improve patient care as well as optimize the use of healthcare resources.
Collapse
Affiliation(s)
- David S Hersh
- 1Division of Neurosurgery, Connecticut Children's, Hartford
- 2Department of Surgery, UConn School of Medicine, Farmington, Connecticut
| | - Jonathan E Martin
- 1Division of Neurosurgery, Connecticut Children's, Hartford
- 2Department of Surgery, UConn School of Medicine, Farmington, Connecticut
| | - Ruth E Bristol
- 3Division of Pediatric Neurosurgery, Department of Surgery, Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, Arizona
| | - Samuel R Browd
- 4Department of Neurosurgery, University of Washington, Seattle Children's Hospital, Seattle, Washington
| | - Gerald Grant
- 5Department of Neurosurgery, Duke University, Durham, North Carolina
| | - Nalin Gupta
- 6Departments of Neurological Surgery and Pediatrics, University of California, San Francisco, California
| | - Todd C Hankinson
- 7Departments of Neurosurgery and Pediatrics, University of Colorado School of Medicine/Children's Hospital Colorado, Aurora, Colorado
| | - Eric M Jackson
- 8Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - John R W Kestle
- 9Division of Pediatric Neurosurgery, Primary Children's Hospital, Salt Lake City
- 10Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Mark D Krieger
- 11Division of Neurological Surgery, Department of Surgery, Children's Hospital Los Angeles
- 12Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California
| | - Abhaya V Kulkarni
- 13Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Casey J Madura
- 14Section of Neurosurgery, Division of Pediatric Neurosciences, Helen DeVos Children's Hospital, Grand Rapids, Michigan
| | - Jonathan Pindrik
- 15Division of Pediatric Neurosurgery, Nationwide Children's Hospital, Columbus
- 16Department of Neurological Surgery, The Ohio State University College of Medicine, Columbus, Ohio
| | - Ian F Pollack
- 17Department of Neurosurgery, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
| | - Jeffrey S Raskin
- 18Division of Pediatric Neurosurgery, Ann and Robert H. Lurie Children's Hospital, Chicago
- 19Department of Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois
| | - Jay Riva-Cambrin
- 20Department of Clinical Neurosciences, University of Calgary, Alberta, Canada
| | - Curtis J Rozzelle
- 21Division of Pediatric Neurosurgery, Children's of Alabama, Birmingham
- 22Department of Neurosurgery, Heersink School of Medicine, University of Alabama at Birmingham, Alabama
| | - Jodi L Smith
- 23Goodman Campbell Brain and Spine, Peyton Manning Children's Hospital at St. Vincent Ascension, Indianapolis, Indiana; and
| | - John C Wellons
- 24Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, Tennessee
| |
Collapse
|
8
|
Chu J, Jensen H, Holubkov R, Krieger MD, Kulkarni AV, Riva-Cambrin J, Rozzelle CJ, Limbrick DD, Wellons JC, Browd SR, Whitehead WE, Pollack IF, Simon TD, Tamber MS, Hauptman JS, Pindrik J, Naftel RP, McDonald PJ, Hankinson TC, Jackson EM, Rocque BG, Reeder R, Drake JM, Kestle JRW. The Hydrocephalus Clinical Research Network quality improvement initiative: the role of antibiotic-impregnated catheters and vancomycin wound irrigation. J Neurosurg Pediatr 2022:1-8. [PMID: 35303708 DOI: 10.3171/2022.2.peds2214] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Accepted: 02/02/2022] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Two previous Hydrocephalus Clinical Research Network (HCRN) studies have demonstrated that compliance with a standardized CSF shunt infection protocol reduces shunt infections. In this third iteration, a simplified protocol consisting of 5 steps was implemented. This analysis provides an updated evaluation of protocol compliance and evaluates modifiable shunt infection risk factors. METHODS The new simplified protocol was implemented at HCRN centers on November 1, 2016, for all shunt procedures, excluding external ventricular drains, ventricular reservoirs, and subgaleal shunts. Procedures performed through December 31, 2019, were included (38 months). Compliance with the protocol, use of antibiotic-impregnated catheters (AICs), and other variables of interest were collected at the index operation. Outcome events for a minimum of 6 months postoperatively were recorded. The definition of infection was unchanged from the authors' previous report. RESULTS A total of 4913 procedures were performed at 13 HCRN centers. The overall infection rate was 5.1%. Surgeons were compliant with all 5 steps of the protocol in 79.4% of procedures. The infection rate for the protocol alone was 8.1% and dropped to 4.9% when AICs were added. Multivariate analysis identified having ≥ 2 complex chronic conditions (odds ratio [OR] 1.76, 95% confidence interval [CI] 1.26-2.44, p = 0.01) and a history of prior shunt surgery within 12 weeks (OR 1.84, 95% CI 1.37-2.47, p < 0.01) as independent risk factors for shunt infection. The use of AICs (OR 0.70, 95% CI 0.50-0.97, p = 0.05) and vancomycin irrigation (OR 0.36, 95% CI 0.21-0.62, p < 0.01) were identified as independent factors protective against shunt infection. CONCLUSIONS The authors report the third iteration of their quality improvement protocol to reduce the risk of shunt infection. Compliance with the protocol was high. These updated data suggest that the incorporation of AICs is an important, modifiable infection prevention measure. Vancomycin irrigation was also identified as a protective factor but requires further study to better understand its role in preventing shunt infection.
Collapse
Affiliation(s)
- Jason Chu
- 1Division of Neurosurgery, Children's Hospital Los Angeles, Department of Neurosurgery, University of Southern California, Los Angeles, California
| | - Hailey Jensen
- 2Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Richard Holubkov
- 2Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Mark D Krieger
- 1Division of Neurosurgery, Children's Hospital Los Angeles, Department of Neurosurgery, University of Southern California, Los Angeles, California
| | - Abhaya V Kulkarni
- 3Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Jay Riva-Cambrin
- 4Department of Clinical Neurosciences, University of Calgary, Alberta, Canada
| | - Curtis J Rozzelle
- 5Section of Pediatric Neurosurgery, Division of Neurosurgery, Children's Hospital of Alabama, University of Alabama-Birmingham, Alabama
| | - David D Limbrick
- 6Department of Neurosurgery, St. Louis Children's Hospital, Washington University in St. Louis, Missouri
| | - John C Wellons
- 7Division of Pediatric Neurosurgery, Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Samuel R Browd
- 8Department of Neurosurgery, University of Washington, Seattle Children's Hospital, Seattle, Washington
| | - William E Whitehead
- 9Division of Pediatric Neurosurgery, Department of Neurosurgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas
| | - Ian F Pollack
- 10Division of Neurosurgery, Children's Hospital of Pittsburgh, Pennsylvania
| | - Tamara D Simon
- 11Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California
| | - Mandeep S Tamber
- 12Department of Surgery, Division of Neurosurgery, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - Jason S Hauptman
- 8Department of Neurosurgery, University of Washington, Seattle Children's Hospital, Seattle, Washington
| | - Jonathan Pindrik
- 13Department of Neurosurgery, Nationwide Children's Hospital, Columbus, Ohio
| | - Robert P Naftel
- 7Division of Pediatric Neurosurgery, Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Patrick J McDonald
- 14Section of Neurosurgery, Department of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Todd C Hankinson
- 15Division of Pediatric Neurosurgery, Department of Neurosurgery, University of Colorado School of Medicine, Aurora, Colorado
| | - Eric M Jackson
- 16Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
| | - Brandon G Rocque
- 5Section of Pediatric Neurosurgery, Division of Neurosurgery, Children's Hospital of Alabama, University of Alabama-Birmingham, Alabama
| | - Ron Reeder
- 2Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - James M Drake
- 3Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - John R W Kestle
- 17Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | | | | |
Collapse
|
9
|
Galambas AK, Krengel WF, Parker CE, Kolenko AM, Browd SR, White KK, Bauer JM. The pediatric "Spine at Risk" program: 9-year review of a novel safety screening tool. Spine Deform 2022; 10:327-334. [PMID: 34705253 DOI: 10.1007/s43390-021-00430-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Accepted: 10/16/2021] [Indexed: 11/26/2022]
Abstract
PURPOSE We implemented an EMR-based "Spine at Risk" (SAR) alert program in 2011 to identify pediatric patients at risk for intraoperative spinal cord injury (SCI) and prompt an evaluation for peri-operative recommendations prior to anesthetic. SAR alerts were activated upon documentation of a qualifying ICD-9/10 diagnosis or manually entered by providers. We aimed to determine the frequency of recommended precautions for those auto-flagged by diagnosis versus by provider, the frequency of precautions, and whether the program prevented SCIs during non-spinal surgery. METHODS We performed a retrospective chart review of patients from 2011 to 19 with an SAR alert. We recorded how the chart was flagged, recommended precautions, and reviewed data for SCIs at our institution during non-spinal operations. RESULTS Of the 3453 patients with an SAR alert over the 9-year study period, 1963 were auto-flagged by diagnosis and 1490 by manual entry. Only 38.7% and 24.3% of the patients in these respective groups were assigned precaution recommendations, making the auto-flag 62.8% better than providers at identifying patients needing precautions. Cervical spine positioning precautions were needed most frequently (86.7% of diagnosis-flagged; 30.0% of provider-flagged), followed by intraoperative neuromonitoring (IONM) (25.2%; 6.1%), thoracolumbar positioning restrictions (16.1%; 7.9%), and fiberoptic intubation (13.9%; 5.7%). There were no SCIs in non-spinal procedures during the study. CONCLUSION EMR-based alerts requiring evaluation by a Neurosurgeon or Orthopaedic surgeon prior to anesthesia can prevent SCIs during non-spinal procedures. The majority of identified patients are not found to be at risk, and will not require special precautions. LEVEL OF EVIDENCE III.
Collapse
Affiliation(s)
| | - Walter F Krengel
- Department of Orthopaedics and Sports Medicine, Department of Orthopaedic Surgery, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, Seattle, WA, 98105, USA
| | - Cheryl E Parker
- Department of Orthopaedic Surgery, Seattle Children's Hospital, Seattle, WA, USA
| | - Ana Maria Kolenko
- Department of Orthopaedic Surgery, Seattle Children's Hospital, Seattle, WA, USA
| | - Samuel R Browd
- Department of Neurosurgery, Seattle Children's Hospital, University of Washington, Seattle, WA, USA
| | - Klane K White
- Department of Orthopaedics and Sports Medicine, Department of Orthopaedic Surgery, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, Seattle, WA, 98105, USA
| | - Jennifer M Bauer
- Department of Orthopaedics and Sports Medicine, Department of Orthopaedic Surgery, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, Seattle, WA, 98105, USA.
| |
Collapse
|
10
|
Pan J, Hauptman JS, Susarla S, Ellenbogen RG, Lee A, Browd SR, Ojemann JG. 377 Complications of Pediatric Tethered Cord Release: Seattle Children’s Hospital Experience. Neurosurgery 2022. [DOI: 10.1227/neu.0000000000001880_377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
11
|
Whitehead WE, Riva-Cambrin J, Wellons JC, Kulkarni AV, Limbrick DD, Wall VL, Rozzelle CJ, Hankinson TC, McDonald PJ, Krieger MD, Pollack IF, Tamber MS, Pindrik J, Hauptman JS, Naftel RP, Shannon CN, Chu J, Jackson EM, Browd SR, Simon TD, Holubkov R, Reeder RW, Jensen H, Koschnitzky JE, Gross P, Drake JM, Kestle JRW. Anterior versus posterior entry site for ventriculoperitoneal shunt insertion: a randomized controlled trial by the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 2021:1-11. [PMID: 34798600 DOI: 10.3171/2021.9.peds21391] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Accepted: 09/02/2021] [Indexed: 11/06/2022]
Abstract
OBJECTIVE The primary objective of this trial was to determine if shunt entry site affects the risk of shunt failure. METHODS The authors performed a parallel-design randomized controlled trial with an equal allocation of patients who received shunt placement via the anterior entry site and patients who received shunt placement via the posterior entry site. All patients were children with symptoms or signs of hydrocephalus and ventriculomegaly. Patients were ineligible if they had a prior history of shunt insertion. Patients received a ventriculoperitoneal shunt after randomization; randomization was stratified by surgeon. The primary outcome was shunt failure. The planned minimum follow-up was 18 months. The trial was designed to achieve high power to detect a 10% or greater absolute difference in the shunt failure rate at 1 year. An independent, blinded adjudication committee determined eligibility and the primary outcome. The study was conducted by the Hydrocephalus Clinical Research Network. RESULTS The study randomized 467 pediatric patients at 14 tertiary care pediatric hospitals in North America from April 2015 to January 2019. The adjudication committee, blinded to intervention, excluded 7 patients in each group for not meeting the study inclusion criteria. For the primary analysis, there were 229 patients in the posterior group and 224 patients in the anterior group. The median patient age was 1.3 months, and the most common etiologies of hydrocephalus were postintraventricular hemorrhage secondary to prematurity (32.7%), myelomeningocele (16.8%), and aqueductal stenosis (10.8%). There was no significant difference in the time to shunt failure between the entry sites (log-rank test, stratified by age < 6 months and ≥ 6 months; p = 0.061). The hazard ratio (HR) of a posterior shunt relative to an anterior shunt was calculated using a univariable Cox regression model and was nonsignificant (HR 1.35, 95% CI, 0.98-1.85; p = 0.062). No significant difference was found between entry sites for the surgery duration, number of ventricular catheter passes, ventricular catheter location, and hospital length of stay. There were no significant differences between entry sites for intraoperative complications, postoperative CSF leaks, pseudomeningoceles, shunt infections, skull fractures, postoperative seizures, new-onset epilepsy, or intracranial hemorrhages. CONCLUSIONS This randomized controlled trial comparing the anterior and posterior shunt entry sites has demonstrated no significant difference in the time to shunt failure. Anterior and posterior entry site surgeries were found to have similar outcomes and similar complication rates.
Collapse
Affiliation(s)
| | - Jay Riva-Cambrin
- 2Department of Neurosurgery, University of Calgary, Calgary, Alberta, Canada
| | - John C Wellons
- 3Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Abhaya V Kulkarni
- 4Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
| | - David D Limbrick
- 5Department of Neurosurgery, Washington University, St. Louis, Missouri
| | - Vanessa L Wall
- 6Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Curtis J Rozzelle
- 7Department of Neurosurgery, University of Alabama, Birmingham, Alabama
| | - Todd C Hankinson
- 8Department of Neurosurgery, University of Colorado, Aurora, Colorado
| | - Patrick J McDonald
- 9Department of Neurosurgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - Mark D Krieger
- 10Department of Neurosurgery, University of Southern California, Los Angeles, California
| | - Ian F Pollack
- 11Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Mandeep S Tamber
- 9Department of Neurosurgery, University of British Columbia, Vancouver, British Columbia, Canada
| | - Jonathan Pindrik
- 12Department of Neurosurgery, Ohio State University, Columbus, Ohio
| | - Jason S Hauptman
- 13Department of Neurosurgery, University of Washington, Seattle, Washington
| | - Robert P Naftel
- 3Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Chevis N Shannon
- 3Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Jason Chu
- 10Department of Neurosurgery, University of Southern California, Los Angeles, California
| | - Eric M Jackson
- 14Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland
| | - Samuel R Browd
- 13Department of Neurosurgery, University of Washington, Seattle, Washington
| | - Tamara D Simon
- 15Department of Pediatrics, Keck School of Medicine at the University of Southern California, Los Angeles, California
| | - Richard Holubkov
- 6Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Ron W Reeder
- 6Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Hailey Jensen
- 6Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | | | - Paul Gross
- 16Hydrocephalus Association, Washington, DC; and
| | - James M Drake
- 4Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
| | - John R W Kestle
- 17Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| |
Collapse
|
12
|
Riva-Cambrin J, Kulkarni AV, Burr R, Rozzelle CJ, Oakes WJ, Drake JM, Alvey JS, Reeder RW, Holubkov R, Browd SR, Cochrane DD, Limbrick DD, Naftel R, Shannon CN, Simon TD, Tamber MS, McDonald PJ, Wellons JC, Luerssen TG, Whitehead WE, Kestle JRW. Impact of ventricle size on neuropsychological outcomes in treated pediatric hydrocephalus: an HCRN prospective cohort study. J Neurosurg Pediatr 2021:1-12. [PMID: 34767531 DOI: 10.3171/2021.8.peds21146] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Accepted: 08/19/2021] [Indexed: 11/06/2022]
Abstract
OBJECTIVE In pediatric hydrocephalus, shunts tend to result in smaller postoperative ventricles compared with those following an endoscopic third ventriculostomy (ETV). The impact of the final treated ventricle size on neuropsychological and quality-of-life outcomes is currently undetermined. Therefore, the authors sought to ascertain whether treated ventricle size is associated with neurocognitive and academic outcomes postoperatively. METHODS This prospective cohort study included children aged 5 years and older at the first diagnosis of hydrocephalus at 8 Hydrocephalus Clinical Research Network sites from 2011 to 2015. The treated ventricle size, as measured by the frontal and occipital horn ratio (FOR), was compared with 25 neuropsychological tests 6 months postoperatively after adjusting for age, hydrocephalus etiology, and treatment type (ETV vs shunt). Pre- and posttreatment grade point average (GPA), quality-of-life measures (Hydrocephalus Outcome Questionnaire [HOQ]), and a truncated preoperative neuropsychological battery were also compared with the FOR. RESULTS Overall, 60 children were included with a mean age of 10.8 years; 17% had ≥ 1 comorbidity. Etiologies for hydrocephalus were midbrain lesions (37%), aqueductal stenosis (22%), posterior fossa tumors (13%), and supratentorial tumors (12%). ETV (78%) was more commonly used than shunting (22%). Of the 25 neuropsychological tests, including full-scale IQ (q = 0.77), 23 tests showed no univariable association with postoperative ventricle size. Verbal learning delayed recall (p = 0.006, q = 0.118) and visual spatial judgment (p = 0.006, q = 0.118) were negatively associated with larger ventricles and remained significant after multivariate adjustment for age, etiology, and procedure type. However, neither delayed verbal learning (p = 0.40) nor visual spatial judgment (p = 0.22) was associated with ventricle size change with surgery. No associations were found between postoperative ventricle size and either GPA or the HOQ. CONCLUSIONS Minimal associations were found between the treated ventricle size and neuropsychological, academic, or quality-of-life outcomes for pediatric patients in this comprehensive, multicenter study that encompassed heterogeneous hydrocephalus etiologies.
Collapse
Affiliation(s)
- Jay Riva-Cambrin
- 1Department of Clinical Neurosciences, Alberta Children's Hospital, University of Calgary, Alberta, Canada
| | - Abhaya V Kulkarni
- 2Department of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Robert Burr
- 4Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Curtis J Rozzelle
- 3Division of Pediatric Neurosurgery, Children's of Alabama, Birmingham, Alabama
| | - W Jerry Oakes
- 3Division of Pediatric Neurosurgery, Children's of Alabama, Birmingham, Alabama
| | - James M Drake
- 2Department of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Jessica S Alvey
- 4Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Ron W Reeder
- 4Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Richard Holubkov
- 4Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Samuel R Browd
- 5Department of Neurological Surgery, Seattle Children's Hospital, Seattle, Washington
| | - D Douglas Cochrane
- 6Division of Pediatric Neurosurgery, BC Children's Hospital, University of British Columbia, Vancouver, Canada
| | - David D Limbrick
- 7Department of Neurosurgery, St. Louis Children's Hospital, St. Louis, Missouri
| | - Robert Naftel
- 8Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Chevis N Shannon
- 8Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Tamara D Simon
- 9Department of Pediatrics, University of Southern California, Los Angeles, California; and
| | - Mandeep S Tamber
- 6Division of Pediatric Neurosurgery, BC Children's Hospital, University of British Columbia, Vancouver, Canada
| | - Patrick J McDonald
- 6Division of Pediatric Neurosurgery, BC Children's Hospital, University of British Columbia, Vancouver, Canada
| | - John C Wellons
- 8Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Thomas G Luerssen
- 10Department of Pediatric Neurosurgery, Texas Children's Hospital, Houston, Texas
| | - William E Whitehead
- 10Department of Pediatric Neurosurgery, Texas Children's Hospital, Houston, Texas
| | - John R W Kestle
- 4Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| |
Collapse
|
13
|
Aboughalia H, Noda S, Chapman T, Revzin MV, Deutsch GH, Browd SR, Katz DS, Moshiri M. Multimodality Imaging Evaluation of Fetal Spine Anomalies with Postnatal Correlation. Radiographics 2021; 41:2176-2192. [PMID: 34723699 DOI: 10.1148/rg.2021210066] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Congenital anomalies of the spine are associated with substantial morbidity in the perinatal period and may affect the rest of the patient's life. Accurate early diagnosis of spinal abnormalities during fetal imaging allows prenatal, perinatal, and postnatal treatment planning, which can substantially affect functional outcomes. The most common and clinically relevant congenital anomalies of the spine fall into three broad categories: spinal dysraphism, segmentation and fusion anomalies of the vertebral column, and sacrococcygeal teratomas. Spinal dysraphism is further categorized into one of two subtypes: open spinal dysraphism and closed spinal dysraphism. The latter category is further subdivided into those with and without subcutaneous masses. Open spinal dysraphism is an emergency and must be closed at birth because of the risk of infection. In utero closure is also offered at some fetal centers. Sacrococcygeal teratomas are the most common fetal pelvic masses and the prognosis is variable. Finally, vertebral body anomalies are categorized into formation (butterfly and hemivertebrae) and segmentation (block vertebrae) anomalies. Although appropriate evaluation of the fetal spine begins with US, which is the initial screening modality of choice, MRI is increasingly important as a problem-solving tool, especially given the recent advances in fetal MRI, its availability, and the complexity of fetal interventions. Online supplemental material is available for this article. ©RSNA, 2021.
Collapse
Affiliation(s)
- Hassan Aboughalia
- From the Departments of Radiology (H.A., S.N., T.C., M.M.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195; Departments of Radiology (S.N., T.C.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), Seattle Children's Hospital, Seattle, Wash; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (M.V.R.); and Department of Radiology, NYU Long Island School of Medicine, Mineola, NY (D.S.K.)
| | - Sakura Noda
- From the Departments of Radiology (H.A., S.N., T.C., M.M.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195; Departments of Radiology (S.N., T.C.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), Seattle Children's Hospital, Seattle, Wash; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (M.V.R.); and Department of Radiology, NYU Long Island School of Medicine, Mineola, NY (D.S.K.)
| | - Teresa Chapman
- From the Departments of Radiology (H.A., S.N., T.C., M.M.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195; Departments of Radiology (S.N., T.C.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), Seattle Children's Hospital, Seattle, Wash; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (M.V.R.); and Department of Radiology, NYU Long Island School of Medicine, Mineola, NY (D.S.K.)
| | - Margarita V Revzin
- From the Departments of Radiology (H.A., S.N., T.C., M.M.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195; Departments of Radiology (S.N., T.C.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), Seattle Children's Hospital, Seattle, Wash; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (M.V.R.); and Department of Radiology, NYU Long Island School of Medicine, Mineola, NY (D.S.K.)
| | - Gail H Deutsch
- From the Departments of Radiology (H.A., S.N., T.C., M.M.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195; Departments of Radiology (S.N., T.C.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), Seattle Children's Hospital, Seattle, Wash; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (M.V.R.); and Department of Radiology, NYU Long Island School of Medicine, Mineola, NY (D.S.K.)
| | - Samuel R Browd
- From the Departments of Radiology (H.A., S.N., T.C., M.M.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195; Departments of Radiology (S.N., T.C.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), Seattle Children's Hospital, Seattle, Wash; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (M.V.R.); and Department of Radiology, NYU Long Island School of Medicine, Mineola, NY (D.S.K.)
| | - Douglas S Katz
- From the Departments of Radiology (H.A., S.N., T.C., M.M.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195; Departments of Radiology (S.N., T.C.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), Seattle Children's Hospital, Seattle, Wash; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (M.V.R.); and Department of Radiology, NYU Long Island School of Medicine, Mineola, NY (D.S.K.)
| | - Mariam Moshiri
- From the Departments of Radiology (H.A., S.N., T.C., M.M.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195; Departments of Radiology (S.N., T.C.), Laboratory Medicine and Pathology (G.H.D.), and Neurological Surgery (S.R.B.), Seattle Children's Hospital, Seattle, Wash; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (M.V.R.); and Department of Radiology, NYU Long Island School of Medicine, Mineola, NY (D.S.K.)
| |
Collapse
|
14
|
Abstract
BACKGROUND Atlantoaxial instability (AAI) is common in pediatric patients with Trisomy 21 and can lead to spinal cord injury during sports, trauma, or anesthetized neck manipulation. Children with Trisomy 21 therefore commonly undergo radiographic cervical spine screening, but recommendations on age and timing vary. The purpose of this study was to determine if instability develops over time. METHODS We performed a retrospective review for all pediatric Trisomy 21 patients receiving at least 2 cervical spine radiographic series between 2008 and 2020 at our institution. Atlantodens interval (ADI) and space available for the cord at C1 (SAC) were measured; bony abnormalities such as os odontoidium, and age and time between radiographs were noted. AAI was determined by ADI ≥6 mm or SAC ≤14 mm based on our groups' prior study. Those who developed instability were compared with those who did not. RESULTS A total of 437 cervical spine radiographic series from 192 patients were evaluated, with 160 included. Mean age at first radiograph was 7.4±4.4 years, average ADI was 3.1 mm (±1.2), and SAC was 18.1 mm (±2.6). The average time between first and last radiographs was 4.3 years (±1.8), with average final ADI 3.2 mm (±1.4) and SAC 18.9 mm (±2.9). Seven patients (4%) had instability: 4 were unstable on their initial studies and 3 (1.6%) on subsequent imaging. Os odontoideum was found in 5 (71%) unstable spines and 3 (2%) stable spines (P<0.0001); only 1 patient that became unstable on subsequent radiograph did not have an os. There was no specific age cut-off or surveillance time period after which one could be determined no longer at risk. CONCLUSIONS Trisomy 21 patients have a 4.4% overall rate of AAI in our series with a 1.6% rate of progression to instability over ∼4 years. Given this nearly 1 in 23 risk of instability, we recommend initial surveillance radiograph for all children over 3 years with Trisomy 21; repeat asymptomatic surveillance should continue in those with os odontoideum given their high instability risk. LEVEL OF EVIDENCE Level II-diagnostic study.
Collapse
Affiliation(s)
- Jennifer M Bauer
- Seattle Children's Hospital Department of Orthopaedic Surgery, University of Washington Department of Orthopaedics and Sports Medicine
| | | | - Samuel R Browd
- Seattle Children's Hospital Department of Neurosurgery, University of Washington Department of Neurosurgery, Seattle, WA
| | - Walter F Krengel
- Seattle Children's Hospital Department of Orthopaedic Surgery, University of Washington Department of Orthopaedics and Sports Medicine
| |
Collapse
|
15
|
Alexiades NG, Shao B, Braga BP, Bonfield CM, Brockmeyer DL, Browd SR, DiLuna M, Groves ML, Hankinson TC, Jea A, Leonard JR, Lew SM, Limbrick DD, Mangano FT, Martin J, Pahys J, Powers A, Proctor MR, Rodriguez L, Rozzelle C, Storm PB, Anderson RCE. Development of best practices in the utilization and implementation of pediatric cervical spine traction: a modified Delphi study. J Neurosurg Pediatr 2021; 27:649-660. [PMID: 33799292 DOI: 10.3171/2020.10.peds20778] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2020] [Accepted: 10/30/2020] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Cervical traction in pediatric patients is an uncommon but invaluable technique in the management of cervical trauma and deformity. Despite its utility, little empirical evidence exists to guide its implementation, with most practitioners employing custom or modified adult protocols. Expert-based best practices may improve the care of children undergoing cervical traction. In this study, the authors aimed to build consensus and establish best practices for the use of pediatric cervical traction in order to enhance its utilization, safety, and efficacy. METHODS A modified Delphi method was employed to try to identify areas of consensus regarding the utilization and implementation of pediatric cervical spine traction. A literature review of pediatric cervical traction was distributed electronically along with a survey of current practices to a group of 20 board-certified pediatric neurosurgeons and orthopedic surgeons with expertise in the pediatric cervical spine. Sixty statements were then formulated and distributed to the group. The results of the second survey were discussed during an in-person meeting leading to further consensus. Consensus was defined as ≥ 80% agreement on a 4-point Likert scale (strongly agree, agree, disagree, strongly disagree). RESULTS After the initial round, consensus was achieved with 40 statements regarding the following topics: goals, indications, and contraindications of traction (12), pretraction imaging (6), practical application and initiation of various traction techniques (8), protocols in trauma and deformity patients (8), and management of traction-related complications (6). Following the second round, an additional 9 statements reached consensus related to goals/indications/contraindications of traction (4), related to initiation of traction (4), and related to complication management (1). All participants were willing to incorporate the consensus statements into their practice. CONCLUSIONS In an attempt to improve and standardize the use of cervical traction in pediatric patients, the authors have identified 49 best-practice recommendations, which were generated by reaching consensus among a multidisciplinary group of pediatric spine experts using a modified Delphi technique. Further study is required to determine if implementation of these practices can lead to reduced complications and improved outcomes for children.
Collapse
Affiliation(s)
- Nikita G Alexiades
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York
| | - Belinda Shao
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York.,2Rutgers New Jersey Medical School, Newark, New Jersey
| | - Bruno P Braga
- 3Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas
| | - Christopher M Bonfield
- 4Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Douglas L Brockmeyer
- 5Department of Pediatric Neurosurgery, Primary Children's Hospital, University of Utah, Salt Lake City, Utah
| | - Samuel R Browd
- 6Department of Neurosurgery, University of Washington/Seattle Children's Hospital, Seattle, Washington
| | - Michael DiLuna
- 7Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut
| | - Mari L Groves
- 8Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Todd C Hankinson
- 9Department of Pediatric Neurosurgery, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Andrew Jea
- 10Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana
| | - Jeffrey R Leonard
- 11Department of Neurosurgery, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio
| | - Sean M Lew
- 12Department of Pediatric Neurosurgery, Children's Wisconsin, Milwaukee, Wisconsin
| | - David D Limbrick
- 13Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri
| | - Francesco T Mangano
- 14Division of Pediatric Neurosurgery, Cincinnati Children's Hospital, Cincinnati, Ohio
| | - Jonathan Martin
- 15Division of Pediatric Neurosurgery, Connecticut Children's Hospital, Hartford, Connecticut
| | - Joshua Pahys
- 16Department of Pediatric Orthopedic Surgery, Shriners Hospital for Children, Philadelphia, Pennsylvania
| | - Alexander Powers
- 17Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, North Carolina
| | - Mark R Proctor
- 18Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts
| | - Luis Rodriguez
- 19Department of Neurosurgery, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
| | - Curtis Rozzelle
- 20Department of Neurosurgery, Division of Pediatric Neurosurgery, University of Alabama, Birmingham; and
| | - Phillip B Storm
- 21Department of Neurosurgery, University of Pennsylvania/Children's Hospital of Philadelphia, Pennsylvania
| | - Richard C E Anderson
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York
| |
Collapse
|
16
|
Williams JR, Young CC, Vitanza NA, McGrath M, Feroze AH, Browd SR, Hauptman JS. Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care. Neurosurg Focus 2021; 48:E4. [PMID: 31896081 DOI: 10.3171/2019.9.focus19745] [Citation(s) in RCA: 34] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Accepted: 09/20/2019] [Indexed: 11/06/2022]
Abstract
Diffuse intrinsic pontine glioma (DIPG) is a universally fatal pediatric brainstem tumor affecting approximately 300 children in the US annually. Median survival is less than 1 year, and radiation therapy has been the mainstay of treatment for decades. Recent advances in the biological understanding of the disease have identified the H3K27M mutation in nearly 80% of DIPGs, leading to the 2016 WHO classification of diffuse midline glioma H3K27M-mutant, a grade IV brainstem tumor. Developments in epigenetic targeting of transcriptional tendencies have yielded potential molecular targets for clinical trials. Chimeric antigen receptor T cell therapy has also shown preclinical promise. Recent clinical studies, including prospective trials, have demonstrated the safety and feasibility of pediatric brainstem biopsy in the setting of DIPG and other brainstem tumors. Given developments in the ability to analyze DIPG tumor tissue to deepen biological understanding of this disease and develop new therapies for treatment, together with the increased safety of stereotactic brainstem biopsy, the authors present a case for offering biopsy to all children with suspected DIPG. They also present their standard operative techniques for image-guided, frameless stereotactic biopsy.
Collapse
Affiliation(s)
- John R Williams
- 1Department of Neurological Surgery, University of Washington
| | | | - Nicholas A Vitanza
- 2Division of Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital; and
| | | | | | - Samuel R Browd
- 3Division of Neurosurgery, Seattle Children's Hospital, Seattle, Washington
| | - Jason S Hauptman
- 3Division of Neurosurgery, Seattle Children's Hospital, Seattle, Washington
| |
Collapse
|
17
|
Sen RD, Lee A, Browd SR, Ellenbogen RG, Hauptman JS. Issues of consent and assent in pediatric neurosurgery. Childs Nerv Syst 2021; 37:33-37. [PMID: 33068156 DOI: 10.1007/s00381-020-04907-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Accepted: 09/28/2020] [Indexed: 12/01/2022]
Abstract
BACKGROUND Consent and assent are important concepts to understand in the care of pediatric neurosurgery patients. Recently it has been recommended that although pediatric patients generally do not have the legal capacity to make medical decisions, they be encouraged to be involved in their own care. Given the paucity of information on this topic in the neurosurgery community, the objective is to provide pediatric neurosurgeons with recommendations on how to involve their patients in medical decision-making. METHODS We review the essential elements and current guidelines of consent and assent for pediatric patients using illustrative neurosurgical case vignettes. RESULTS The pediatric population ranges widely in cognitive and psychological development making the process of consent and assent quite complex. The role of the child or adolescent in medical decision-making, issues associated with obtaining assent or dissent, and informed refusal of treatment are considered. CONCLUSION The process of obtaining consent and assent represents a critical yet often overlooked aspect to care of pediatric neurosurgical patients. The pediatric neurosurgeon must be able to distill immensely complex and high-risk procedures into simple, understandable terms. Furthermore, they must recognize when the child's dissent or refusal to treatment is acceptable. In general, allowing children to be involved in their neurosurgical care is empowering and gives them both identity and agency, which is the vital first step to a successful neurosurgical intervention.
Collapse
Affiliation(s)
- Rajeev D Sen
- Department of Neurological Surgery, University of Washington, 325 Ninth Ave., Seattle, WA, 98104, USA.
| | - Amy Lee
- Department of Neurological Surgery, University of Washington, 325 Ninth Ave., Seattle, WA, 98104, USA.,Department of Neurosurgery, Seattle Children's Hospital, Seattle, WA, USA
| | - Samuel R Browd
- Department of Neurological Surgery, University of Washington, 325 Ninth Ave., Seattle, WA, 98104, USA.,Department of Neurosurgery, Seattle Children's Hospital, Seattle, WA, USA
| | - Richard G Ellenbogen
- Department of Neurological Surgery, University of Washington, 325 Ninth Ave., Seattle, WA, 98104, USA.,Department of Neurosurgery, Seattle Children's Hospital, Seattle, WA, USA
| | - Jason S Hauptman
- Department of Neurological Surgery, University of Washington, 325 Ninth Ave., Seattle, WA, 98104, USA.,Department of Neurosurgery, Seattle Children's Hospital, Seattle, WA, USA
| |
Collapse
|
18
|
Biery MC, Noll A, Myers C, Morris SM, Winter CA, Pakiam F, Cole BL, Browd SR, Olson JM, Vitanza NA. A Protocol for the Generation of Treatment-naïve Biopsy-derived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models. J Exp Neurol 2020. [PMID: 33768215 PMCID: PMC7990285 DOI: 10.33696//neurol.1.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Diffuse intrinsic pontine glioma (DIPG) is a universally fatal tumor of the brainstem, most commonly affecting young children. Due to its location, surgical resection is not achievable, but consideration of a biopsy has become standard practice at children’s hospitals with the appropriate neurosurgical expertise. While the decision to obtain a biopsy should be directed by the presence of atypical radiographic features that call the diagnosis of DIPG into question or the requirement of biopsy tissue for clinical trial enrollment, once this precious tissue is available its use for research should be considered. The majority of DIPG and diffuse midline glioma, H3 K27M-mutant (DMG) models are autopsy-derived or genetically-engineered, each of which has limitations for translational studies, so the use of biopsy tissue for laboratory model development provides an opportunity to create unique model systems. Here, we present a detailed laboratory protocol for the generation of treatment-naïve biopsy-derived DIPG/DMG models.
Collapse
Affiliation(s)
- Matt C Biery
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Alyssa Noll
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA.,Molecular and Cellular Biology Graduate Program and Medical Scientist Training Program, University of Washington, Seattle, WA, USA
| | - Carrie Myers
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | | | - Conrad A Winter
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA.,Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA
| | - Fiona Pakiam
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Bonnie L Cole
- Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA.,Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA
| | - Samuel R Browd
- Division of Neurosurgery, Department of Neurological Surgery, University of Washington, Seattle Children's Hospital, Seattle, WA, USA
| | - James M Olson
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA.,Division of Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA
| | - Nicholas A Vitanza
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA.,Division of Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA
| |
Collapse
|
19
|
Hauptman JS, Kestle J, Riva-Cambrin J, Kulkarni AV, Browd SR, Rozzelle CJ, Whitehead WE, Naftel RP, Pindrik J, Limbrick DD, Drake J, Wellons JC, Tamber MS, Shannon CN, Simon TD, Pollack IF, McDonald PJ, Krieger MD, Chu J, Hankinson TC, Jackson EM, Alvey JS, Reeder RW, Holubkov R. Predictors of fast and ultrafast shunt failure in pediatric hydrocephalus: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2020; 27:277-286. [PMID: 33338993 DOI: 10.3171/2020.7.peds20111] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2020] [Accepted: 07/16/2020] [Indexed: 11/06/2022]
Abstract
OBJECTIVE The primary objective of this study was to use the prospective Hydrocephalus Clinical Research Network (HCRN) registry to determine clinical predictors of fast time to shunt failure (≤ 30 days from last revision) and ultrafast time to failure (≤ 7 days from last revision). METHODS Revisions (including those due to infection) to permanent shunt placements that occurred between April 2008 and November 2017 for patients whose entire shunt experience was recorded in the registry were analyzed. All registry data provided at the time of initial shunt placement and subsequent revision were reviewed. Key variables analyzed included etiology of hydrocephalus, age at time of initial shunt placement, presence of slit ventricles on imaging at revision, whether the ventricles were enlarged at the time of revision, and presence of prior fast failure events. Univariable and multivariable analyses were performed to find key predictors of fast and ultrafast failure events. RESULTS A cohort of 1030 patients with initial shunt insertions experienced a total of 1995 revisions. Of the 1978 revision events with complete records, 1216 (61.5%) shunts remained functional for more than 1 year, and 762 (38.5%) failed within 1 year of the procedure date. Of those that failed within 1 year, 423 (55.5%) failed slowly (31-365 days) and 339 (44.5%) failed fast (≤ 30 days). Of the fast failures, 131 (38.6%) were ultrafast (≤ 7 days). In the multivariable analysis specified a priori, etiology of hydrocephalus (p = 0.005) and previous failure history (p = 0.011) were independently associated with fast failure. Age at time of procedure (p = 0.042) and etiology of hydrocephalus (p = 0.004) were independently associated with ultrafast failure. These relationships in both a priori models were supported by the data-driven multivariable models as well. CONCLUSIONS Neither the presence of slit ventricle syndrome nor ventricular enlargement at the time of shunt failure appears to be a significant predictor of repeated, rapid shunt revisions. Age at the time of procedure, etiology of hydrocephalus, and the history of previous failure events seem to be important predictors of fast and ultrafast shunt failure. Further work is required to understand the mechanisms of these risk factors as well as mitigation strategies.
Collapse
Affiliation(s)
- Jason S Hauptman
- 1Department of Neurosurgery, University of Washington, Seattle Children's Hospital, Seattle, Washington
| | - John Kestle
- 2Division of Pediatric Neurosurgery, Department of Neurosurgery, Primary Children's Medical Center, University of Utah, Salt Lake City, Utah
| | - Jay Riva-Cambrin
- 3Department of Neurosurgery, University of Calgary, Alberta, Canada
| | - Abhaya V Kulkarni
- 4Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Samuel R Browd
- 1Department of Neurosurgery, University of Washington, Seattle Children's Hospital, Seattle, Washington
| | - Curtis J Rozzelle
- 5Section of Pediatric Neurosurgery, Division of Neurosurgery, Children's Hospital of Alabama, University of Alabama-Birmingham, Alabama
| | - William E Whitehead
- 6Division of Pediatric Neurosurgery, Department of Neurosurgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas
| | - Robert P Naftel
- 7Division of Pediatric Neurosurgery, Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Jonathan Pindrik
- 8Department of Neurosurgery, Nationwide Children's Hospital, Columbus, Ohio
| | - David D Limbrick
- 9Department of Neurosurgery, St. Louis Children's Hospital, Washington University in St. Louis, Missouri
| | - James Drake
- 4Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - John C Wellons
- 7Division of Pediatric Neurosurgery, Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Mandeep S Tamber
- 10University of British Columbia Department of Surgery, Division of Neurosurgery, British Columbia Children's Hospital, Vancouver, British Columbia, Canada
| | - Chevis N Shannon
- 7Division of Pediatric Neurosurgery, Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Tamara D Simon
- 11Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington
| | - Ian F Pollack
- 12Division of Neurosurgery, Children's Hospital of Pittsburgh, Pennsylvania
| | - Patrick J McDonald
- 10University of British Columbia Department of Surgery, Division of Neurosurgery, British Columbia Children's Hospital, Vancouver, British Columbia, Canada
| | - Mark D Krieger
- 13Division of Neurosurgery, Children's Hospital Los Angeles, California
| | - Jason Chu
- 13Division of Neurosurgery, Children's Hospital Los Angeles, California
| | - Todd C Hankinson
- 14Division of Pediatric Neurosurgery, Department of Neurosurgery, University of Colorado School of Medicine, Aurora, Colorado; and
| | - Eric M Jackson
- 15Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Jessica S Alvey
- 2Division of Pediatric Neurosurgery, Department of Neurosurgery, Primary Children's Medical Center, University of Utah, Salt Lake City, Utah
| | - Ron W Reeder
- 2Division of Pediatric Neurosurgery, Department of Neurosurgery, Primary Children's Medical Center, University of Utah, Salt Lake City, Utah
| | - Richard Holubkov
- 2Division of Pediatric Neurosurgery, Department of Neurosurgery, Primary Children's Medical Center, University of Utah, Salt Lake City, Utah
| | | |
Collapse
|
20
|
Tamber MS, Kestle JRW, Reeder RW, Holubkov R, Alvey J, Browd SR, Drake JM, Kulkarni AV, Limbrick DD, McDonald PJ, Rozzelle CJ, Simon TD, Naftel R, Shannon CN, Wellons JC, Whitehead WE, Riva-Cambrin J. Temporal trends in surgical procedures for pediatric hydrocephalus: an analysis of the Hydrocephalus Clinical Research Network Core Data Project. J Neurosurg Pediatr 2020; 27:269-276. [PMID: 33338996 DOI: 10.3171/2020.7.peds20142] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Accepted: 07/16/2020] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Analysis of temporal trends in patient populations and procedure types may provide important information regarding the evolution of hydrocephalus treatment. The purpose of this study was to use the Hydrocephalus Clinical Research Network's Core Data Project to identify meaningful trends in patient characteristics and the surgical management of pediatric hydrocephalus over a 9-year period. METHODS The Core Data Project prospectively collected patient and procedural data on the study cohort from 9 centers between 2008 and 2016. Logistic and Poisson regression were used to test for significant temporal trends in patient characteristics and new and revision hydrocephalus procedures. RESULTS The authors analyzed 10,149 procedures in 5541 patients. New procedures for hydrocephalus (shunt or endoscopic third ventriculostomy [ETV]) decreased by 1.5%/year (95% CI -3.1%, +0.1%). During the study period, new shunt insertions decreased by 6.5%/year (95% CI -8.3%, -4.6%), whereas new ETV procedures increased by 12.5%/year (95% CI 9.3%, 15.7%). Revision procedures for hydrocephalus (shunt or ETV) decreased by 4.2%/year (95% CI -5.2%, -3.1%), driven largely by a decrease of 5.7%/year in shunt revisions (95% CI -6.8%, -4.6%). Concomitant with the observed increase in new ETV procedures was an increase in ETV revisions (13.4%/year, 95% CI 9.6%, 17.2%). Because revisions decreased at a faster rate than new procedures, the Revision Quotient (ratio of revisions to new procedures) for the Network decreased significantly over the study period (p = 0.0363). No temporal change was observed in the age or etiology characteristics of the cohort, although the proportion of patients with one or more complex chronic conditions significantly increased over time (p = 0.0007). CONCLUSIONS Over a relatively short period, important changes in hydrocephalus care have been observed. A significant temporal decrease in revision procedures amid the backdrop of a more modest change in new procedures appears to be the most notable finding and may be indicative of an improvement in the quality of surgical care for pediatric hydrocephalus. Further studies will be directed at elucidation of the possible drivers of the observed trends.
Collapse
Affiliation(s)
- Mandeep S Tamber
- 1Division of Neurosurgery, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - John R W Kestle
- 2Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Ron W Reeder
- 2Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Richard Holubkov
- 2Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Jessica Alvey
- 2Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Samuel R Browd
- 3Department of Neurological Surgery, Seattle Children's Hospital, Seattle, Washington
| | - James M Drake
- 4Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Abhaya V Kulkarni
- 4Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - David D Limbrick
- 5Department of Neurosurgery, St. Louis Children's Hospital, St. Louis, Missouri
| | - Patrick J McDonald
- 1Division of Neurosurgery, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - Curtis J Rozzelle
- 6Department of Neurosurgery, Children's Hospital of Alabama, Birmingham, Alabama
| | - Tamara D Simon
- 3Department of Neurological Surgery, Seattle Children's Hospital, Seattle, Washington
| | - Robert Naftel
- 7Department of Neurological Surgery, Vanderbilt University, Nashville, Tennessee
| | - Chevis N Shannon
- 7Department of Neurological Surgery, Vanderbilt University, Nashville, Tennessee
| | - John C Wellons
- 7Department of Neurological Surgery, Vanderbilt University, Nashville, Tennessee
| | | | - Jay Riva-Cambrin
- 9Department of Clinical Neurosciences, Alberta Children's Hospital, University of Calgary, Alberta, Canada
| | | |
Collapse
|
21
|
Biery MC, Noll A, Myers C, Morris SM, Winter CA, Pakiam F, Cole BL, Browd SR, Olson JM, Vitanza NA. A Protocol for the Generation of Treatment-naïve Biopsy-derived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models. J Exp Neurol 2020; 1:158-167. [PMID: 33768215 PMCID: PMC7990285 DOI: 10.33696/neurol.1.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/28/2023]
Abstract
Diffuse intrinsic pontine glioma (DIPG) is a universally fatal tumor of the brainstem, most commonly affecting young children. Due to its location, surgical resection is not achievable, but consideration of a biopsy has become standard practice at children's hospitals with the appropriate neurosurgical expertise. While the decision to obtain a biopsy should be directed by the presence of atypical radiographic features that call the diagnosis of DIPG into question or the requirement of biopsy tissue for clinical trial enrollment, once this precious tissue is available its use for research should be considered. The majority of DIPG and diffuse midline glioma, H3 K27M-mutant (DMG) models are autopsy-derived or genetically-engineered, each of which has limitations for translational studies, so the use of biopsy tissue for laboratory model development provides an opportunity to create unique model systems. Here, we present a detailed laboratory protocol for the generation of treatment-naïve biopsy-derived DIPG/DMG models.
Collapse
Affiliation(s)
- Matt C. Biery
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Alyssa Noll
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Molecular and Cellular Biology Graduate Program and Medical Scientist Training Program, University of Washington, Seattle, WA, USA
| | - Carrie Myers
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | | | - Conrad A. Winter
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Department of Laboratories, Seattle Children’s Hospital, Seattle, WA, USA
| | - Fiona Pakiam
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Bonnie L. Cole
- Department of Laboratories, Seattle Children’s Hospital, Seattle, WA, USA
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA
| | - Samuel R. Browd
- Division of Neurosurgery, Department of Neurological Surgery, University of Washington, Seattle Children’s Hospital, Seattle, WA, USA
| | - James M. Olson
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Division of Hematology/Oncology, Department of Pediatrics, Seattle Children’s Hospital, University of Washington, Seattle, WA, USA
| | - Nicholas A. Vitanza
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Division of Hematology/Oncology, Department of Pediatrics, Seattle Children’s Hospital, University of Washington, Seattle, WA, USA
| |
Collapse
|
22
|
Bass DI, Lee A, Browd SR, Ellenbogen RG, Hauptman JS. Medicolegal issues in abusive head trauma for the pediatric neurosurgeon. Neurosurg Focus 2020; 49:E23. [PMID: 33130608 DOI: 10.3171/2020.8.focus20599] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2020] [Accepted: 08/18/2020] [Indexed: 11/06/2022]
Abstract
The purpose of this article is to serve as a rational guide for the pediatric neurosurgeon in navigating common medicolegal issues that arise in the management of abusive head trauma (AHT). Many of these issues may be unfamiliar or unpleasant to surgeons focused on addressing disease. The authors begin with a brief history on the origins of the diagnosis of AHT and the controversy surrounding it, highlighting some of the facets of the diagnosis that make it particularly unique in pediatric neurosurgery. They then review some special medical considerations in these patients through the perspective of the neurosurgeon and provide several examples as illustration. The authors discuss how to appropriately document these cases in the medical record for expected legal review, and last, they provide an overview of the legal process through which the neurosurgeon may be called to provide testimony.
Collapse
Affiliation(s)
- David I Bass
- 1Department of Neurological Surgery, University of Washington; and
| | - Amy Lee
- 1Department of Neurological Surgery, University of Washington; and.,2Department of Neurosurgery, Seattle Children's Hospital, Seattle, Washington
| | - Samuel R Browd
- 1Department of Neurological Surgery, University of Washington; and.,2Department of Neurosurgery, Seattle Children's Hospital, Seattle, Washington
| | - Richard G Ellenbogen
- 1Department of Neurological Surgery, University of Washington; and.,2Department of Neurosurgery, Seattle Children's Hospital, Seattle, Washington
| | - Jason S Hauptman
- 1Department of Neurological Surgery, University of Washington; and.,2Department of Neurosurgery, Seattle Children's Hospital, Seattle, Washington
| |
Collapse
|
23
|
Chrisman SPD, Hays R, Levesque R, MacDonald C, Herring SA, Browd SR. Pilot Study Of A 12 Week Intervention (AERIAL©) To Teach Youth To Head The Ball Safely. Med Sci Sports Exerc 2020. [DOI: 10.1249/01.mss.0000670640.22510.51] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
24
|
Wright JN, Feyma TJ, Ishak GE, Abeshaus S, Metz JB, Brown ECB, Friedman SD, Browd SR, Feldman KW. Correction to: Subdural hemorrhage rebleeding in abused children: frequency, associations and clinical presentation. Pediatr Radiol 2020; 50:1161. [PMID: 32444953 DOI: 10.1007/s00247-020-04687-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The original article included a statement which is not fully accurate. This correction clarifies the original statement.
Collapse
Affiliation(s)
- Jason N Wright
- Department of Radiology, Seattle Children's Hospital, Harborview Medical Center, Seattle, WA, USA.,University of Washington, Seattle, WA, USA
| | - Timothy J Feyma
- Department of Neurology, Gillette Children's Specialty Health Care, St. Paul, MN, USA
| | - Gisele E Ishak
- Department of Radiology, Seattle Children's Hospital, Harborview Medical Center, Seattle, WA, USA.,University of Washington, Seattle, WA, USA
| | - Sergey Abeshaus
- Department of Neurosurgery, Rambam Health Care Campus, Haifa, Israel
| | - James B Metz
- Department of Pediatrics, University of Vermont School of Medicine, Burlington, VT, USA
| | - Emily C B Brown
- University of Washington, Seattle, WA, USA.,Department of Pediatrics, Children's Protection Program, M/S SB-250, Seattle Children's Hospital, Harborview Medical Center, 4800 Sand Point Way NE, Seattle, WA, 98105, USA
| | - Seth D Friedman
- Department of Radiology, Seattle Children's Hospital, Harborview Medical Center, Seattle, WA, USA.,University of Washington, Seattle, WA, USA
| | - Samuel R Browd
- University of Washington, Seattle, WA, USA.,Department of Neurological Surgery, Seattle Children's Hospital, Harborview Medical Center, Seattle, WA, USA
| | - Kenneth W Feldman
- University of Washington, Seattle, WA, USA. .,Department of Pediatrics, Children's Protection Program, M/S SB-250, Seattle Children's Hospital, Harborview Medical Center, 4800 Sand Point Way NE, Seattle, WA, 98105, USA.
| |
Collapse
|
25
|
Prolo LM, Bass DI, Bauer JM, Browd SR. Letter to the Editor. Posterior transdural approach for cervical stenosis caused by retroflexion of anterior elements in a child with Pfeiffer syndrome. J Neurosurg Pediatr 2020; 25:1-2. [PMID: 32168492 DOI: 10.3171/2020.1.peds2031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
26
|
Rivara FP, Tennyson R, Mills B, Browd SR, Emery CA, Gioia G, Giza CC, Herring S, Janz KF, LaBella C, Valovich McLeod T, Meehan W, Patricios J. Consensus Statement on Sports-Related Concussions in Youth Sports Using a Modified Delphi Approach. JAMA Pediatr 2020; 174:79-85. [PMID: 31710349 DOI: 10.1001/jamapediatrics.2019.4006] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
IMPORTANCE Given the importance of sports-related concussions among youth athletes, the rapid progress of research on this topic over the last decade, and the need to provide further guidance to youth athletes, their families, medical professionals, and athletic personnel and organizations, a panel of experts undertook a modified Delphi consensus process to summarize the current literature and provide recommendations regarding the prevention, assessment, and management of sports-related concussions for young athletes. METHODS A consensus panel of 11 experts was created to represent a broad spectrum of expertise in youth sports and concussions. The specific questions to be addressed were developed through an iterative process consisting of 3 rounds, and a review of the literature was conducted to identify research studies related to each question. The consensus panel used a modified Delphi process to reach consensus on the conclusions and recommendations for each question. RESULTS AND CONCLUSIONS In 3 Delphi consensus rounds, 7 questions were addressed by the consensus panel of 11 experts, and 26 recommendations for the prevention, assessment, and management of sports-related concussions among young athletes were developed. For many of the questions addressed in this consensus statement, limitations existed in the quantity and quality of the evidence available to develop specific recommendations for youth sports stakeholders.
Collapse
Affiliation(s)
- Frederick P Rivara
- Department of Pediatrics, Harborview Injury Prevention and Research Center, University of Washington, Seattle.,Department of Epidemiology, Harborview Injury Prevention and Research Center, University of Washington, Seattle.,Center for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, Washington
| | - Robert Tennyson
- Harborview Injury Prevention and Research Center, University of Washington, Seattle
| | - Brianna Mills
- Harborview Injury Prevention and Research Center, University of Washington, Seattle
| | - Samuel R Browd
- Department of Neurological Surgery, The Sports Institute, UW Medicine and Seattle Children's Research Institute, Seattle, Washington
| | - Carolyn A Emery
- Faculty of Kinesiology and Community Health Sciences and Pediatrics, Sport Injury Prevention Research Centre, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Gerald Gioia
- Department of Pediatrics, George Washington University School of Medicine, Washington, DC.,Department of Psychiatry and Behavioral Sciences, George Washington University School of Medicine, Washington, DC.,Children's National Health System, Washington, DC
| | - Christopher C Giza
- Steve Tisch BrainSPORT Program, University of California, Los Angeles.,Department of Pediatrics, Mattel Children's Hospital and David Geffen School of Medicine, Los Angeles, California.,Department of Neurosurgery, Mattel Children's Hospital and David Geffen School of Medicine, Los Angeles, California
| | - Stanley Herring
- Department of Neurological Surgery, The Sports Institute, UW Medicine and Seattle Children's Research Institute, Seattle, Washington.,Department of Rehabilitation Medicine, Orthopedics, and Sports Medicine, The Sports Institute, UW Medicine and Seattle Children's Research Institute, Seattle, Washington
| | - Kathleen F Janz
- Department of Health and Human Physiology, University of Iowa, Iowa City
| | - Cynthia LaBella
- Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.,The Institute for Sports Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
| | - Tamara Valovich McLeod
- Athletic Training Programs and Research, School of Osteopathic Medicine, A. T. Stills University, Mesa, Arizona
| | - William Meehan
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.,Department of Orthopedics, Harvard Medical School, Boston, Massachusetts.,Micheli Center for Sports Injury Prevention, Waltham, Massachusetts.,Brain Injury Center, Boston Children's Hospital, Boston, Massachusetts
| | - Jon Patricios
- Department of Health Sciences, Wits Institute for Sport and Health, University of Witwatersrand, Johannesburg, South Africa.,Waterfall Sports Orthopaedic Surgery, Johannesburg, South Africa
| | | |
Collapse
|
27
|
Bonow RH, Oron AP, Hanak BW, Browd SR, Chesnut RM, Ellenbogen RG, Vavilala MS, Rivara FP. Post-Traumatic Hydrocephalus in Children: A Retrospective Study in 42 Pediatric Hospitals Using the Pediatric Health Information System. Neurosurgery 2019; 83:732-739. [PMID: 29029289 DOI: 10.1093/neuros/nyx470] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2017] [Accepted: 08/30/2017] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Post-traumatic hydrocephalus (PTH) is a potentially treatable cause of poor recovery from traumatic brain injury (TBI) that remains poorly understood, particularly among children. OBJECTIVE To better understand the risk factors for pediatric PTH using a large, multi-institutional database. METHODS We conducted a retrospective cohort study using administrative data from 42 pediatric hospitals participating in the Pediatric Health Information System. All patients ≤21 yr surviving a hospitalization with an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code for TBI were identified. The primary outcome was PTH, defined by an ICD-9-CM procedure code for surgical management of hydrocephalus within 6 mo. Data were analyzed using multivariable logistic regression. RESULTS We identified 91 583 patients ≤21 yr with TBI, 846 of whom developed PTH. Odds of PTH were significantly higher in children <1 yr compared to older age groups. A total of 48.7% of PTH cases were victims of abuse (adjusted odds ratio [aOR] 2.62, 95% confidence interval [CI] 2.16-3.18). PTH was more common after craniotomy (aOR 1.60, 95% CI 1.30-1.97). Craniectomy without early cranioplasty was associated with markedly increased odds of PTH (aOR 3.67, 95% CI 2.66-5.07), an effect not seen in those undergoing cranioplasty within 30 d (aOR 1.19, 95% CI 0.75-1.89). CONCLUSION PTH was seen in 0.9% of children who sustained a TBI and was more common in those <1 yr. Severe injury, abuse, and craniectomy with delayed cranioplasty were associated with greatly increased likelihood of PTH. Early cranioplasty in children who require craniectomy may reduce the risk for PTH.
Collapse
Affiliation(s)
- Robert H Bonow
- Department of Neurological Surgery, University of Washington, Seattle, Washington.,Harborview Injury Prevention Research Center, Harborview Medical Center, Seattle, Washington
| | - Assaf P Oron
- Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington
| | - Brian W Hanak
- Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Samuel R Browd
- Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Randall M Chesnut
- Department of Neurological Surgery, University of Washington, Seattle, Washington.,Harborview Injury Prevention Research Center, Harborview Medical Center, Seattle, Washington
| | - Richard G Ellenbogen
- Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Monica S Vavilala
- Harborview Injury Prevention Research Center, Harborview Medical Center, Seattle, Washington.,Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington
| | - Frederick P Rivara
- Harborview Injury Prevention Research Center, Harborview Medical Center, Seattle, Washington.,Department of Pediatrics, University of Washington, Seattle, Washington
| |
Collapse
|
28
|
LoPresti M, Lam S, Orrico K, Browd SR, Ellenbogen RG, Martin J. Advocacy in pediatric neurosurgery: results from a 2017 survey of the American Society of Pediatric Neurosurgeons. J Neurosurg Pediatr 2019; 24:1-5. [PMID: 31252384 DOI: 10.3171/2019.4.peds1911] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2019] [Accepted: 04/25/2019] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Pediatric neurosurgeons are unswerving advocates for public health-related issues in children, with most providers participating in local, regional, national, or international efforts. Collective advocacy efforts by organized pediatric neurosurgeons have not been undertaken to date. METHODS A 10-item survey was administered to members of the American Society of Pediatric Neurosurgeons (ASPN) in order to evaluate attitudes and opinions regarding the development of a formal advocacy effort by the organization. RESULTS Seventy-nine of 178 registered members of the ASPN (44.38%) participated in the survey. Participants were 82.61% male, with age, stage of career, and practice type varied. Although there was unequivocal support for participation in organized advocacy, respondents were divided on methods and topics for advocacy. In this survey, the ASPN membership prioritized public health and clinical issues over economic issues that affected children. CONCLUSIONS Most respondents favored the drafting of position statements on key issues and partnerships with larger organizations to pursue an advocacy agenda. The survey provides data regarding pediatric neurosurgeons' attitudes that may assist with the design of a successful advocacy program.
Collapse
Affiliation(s)
- Melissa LoPresti
- 1Division of Pediatric Neurosurgery, Texas Children's Hospital
- 2Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - Sandi Lam
- 1Division of Pediatric Neurosurgery, Texas Children's Hospital
- 2Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - Katie Orrico
- 3Washington Office, American Association of Neurological Surgeons/Congress of Neurosurgeons, Washington, DC
| | - Samuel R Browd
- 4Division of Pediatric Neurosurgery, Seattle Children's Hospital
- 5Department of Neurosurgery, University of Washington School of Medicine, Seattle, Washington
| | - Richard G Ellenbogen
- 4Division of Pediatric Neurosurgery, Seattle Children's Hospital
- 5Department of Neurosurgery, University of Washington School of Medicine, Seattle, Washington
| | - Jonathan Martin
- 6Division of Pediatric Neurosurgery, Connecticut Children's, Hartford; and
- 7Department of Neurosurgery, University of Connecticut School of Medicine, Farmington, Connecticut
| |
Collapse
|
29
|
Riva-Cambrin J, Kestle JRW, Rozzelle CJ, Naftel RP, Alvey JS, Reeder RW, Holubkov R, Browd SR, Cochrane DD, Limbrick DD, Shannon CN, Simon TD, Tamber MS, Wellons JC, Whitehead WE, Kulkarni AV. Predictors of success for combined endoscopic third ventriculostomy and choroid plexus cauterization in a North American setting: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2019; 24:128-138. [PMID: 31151098 DOI: 10.3171/2019.3.peds18532] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2018] [Accepted: 03/12/2019] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Endoscopic third ventriculostomy combined with choroid plexus cauterization (ETV+CPC) has been adopted by many pediatric neurosurgeons as an alternative to placing shunts in infants with hydrocephalus. However, reported success rates have been highly variable, which may be secondary to patient selection, operative technique, and/or surgeon training. The objective of this prospective multicenter cohort study was to identify independent patient selection, operative technique, or surgical training predictors of ETV+CPC success in infants. METHODS This was a prospective cohort study nested within the Hydrocephalus Clinical Research Network's (HCRN) Core Data Project (registry). All infants under the age of 2 years who underwent a first ETV+CPC between June 2006 and March 2015 from 8 HCRN centers were included. Each patient had a minimum of 6 months of follow-up unless censored by an ETV+CPC failure. Patient and operative risk factors of failure were examined, as well as formal ETV+CPC training, which was defined as traveling to and working with the experienced surgeons at CURE Children's Hospital of Uganda. ETV+CPC failure was defined as the need for repeat ETV, shunting, or death. RESULTS The study contained 191 patients with a primary ETV+CPC conducted by 17 pediatric neurosurgeons within the HCRN. Infants under 6 months corrected age at the time of ETV+CPC represented 79% of the cohort. Myelomeningocele (26%), intraventricular hemorrhage associated with prematurity (24%), and aqueductal stenosis (17%) were the most common etiologies. A total of 115 (60%) of the ETV+CPCs were conducted by surgeons after formal training. Overall, ETV+CPC was successful in 48%, 46%, and 45% of infants at 6 months, 1 year, and 18 months, respectively. Young age (< 1 month) (adjusted hazard ratio [aHR] 1.9, 95% CI 1.0-3.6) and an etiology of post-intraventricular hemorrhage secondary to prematurity (aHR 2.0, 95% CI 1.1-3.6) were the only two independent predictors of ETV+CPC failure. Specific subgroups of ages within etiology categories were identified as having higher ETV+CPC success rates. Although training led to more frequent use of the flexible scope (p < 0.001) and higher rates of complete (> 90%) CPC (p < 0.001), training itself was not independently associated (aHR 1.1, 95% CI 0.7-1.8; p = 0.63) with ETV+CPC success. CONCLUSIONS This is the largest prospective multicenter North American study to date examining ETV+CPC. Formal ETV+CPC training was not found to be associated with improved procedure outcomes. Specific subgroups of ages within specific hydrocephalus etiologies were identified that may preferentially benefit from ETV+CPC.
Collapse
Affiliation(s)
- Jay Riva-Cambrin
- 1Alberta Children's Hospital, University of Calgary, Alberta, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Chu JK, Feroze AH, Collins K, McGrath LB, Young CC, Williams JR, Browd SR. Variation in hospital charges in patients with external ventricular drains: comparison between the intensive care and surgical floor settings. J Neurosurg Pediatr 2019; 24:29-34. [PMID: 31003227 DOI: 10.3171/2019.2.peds18545] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2018] [Accepted: 02/08/2019] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Placement of an external ventricular drain (EVD) is a common and potentially life-saving neurosurgical procedure, but the economic aspect of EVD management and the relationship to medical expenditure remain poorly studied. Similarly, interinstitutional practice patterns vary significantly. Whereas some institutions require that patients with EVDs be monitored strictly within the intensive care unit (ICU), other institutions opt primarily for management of EVDs on the surgical floor. Therefore, an ICU burden for patients with EVDs may increase a patient's costs of hospitalization. The objective of the current study was to examine the expense differences between the ICU and the general neurosurgical floor for EVD care. METHODS The authors performed a retrospective analysis of data from 2 hospitals within a single, large academic institution-the University of Washington Medical Center (UWMC) and Seattle Children's Hospital (SCH). Hospital charges were evaluated according to patients' location at the time of EVD management: SCH ICU, SCH floor, or UWMC ICU. Daily hospital charges from day of EVD insertion to day of removal were included and screened for days that would best represent baseline expenses for EVD care. Independent-samples Kruskal-Wallis analysis was performed to compare daily charges for the 3 settings. RESULTS Data from a total of 261 hospital days for 23 patients were included in the analysis. Ten patients were cared for in the UWMC ICU and 13 in the SCH ICU and/or on the SCH neurosurgical floor. The median values for total daily hospital charges were $19,824.68 (interquartile range [IQR] $12,889.73-$38,494.81) for SCH ICU care, $8,620.88 (IQR $6,416.76-$11,851.36) for SCH floor care, and $10,002.13 (IQR $8,465.16-$12,123.03) for UWMC ICU care. At SCH, it was significantly more expensive to provide EVD care in the ICU than on the floor (p < 0.001), and the daily hospital charges for the UWMC ICU were significantly greater than for the SCH floor (p = 0.023). No adverse clinical event related to the presence of an EVD was identified in any of the settings. CONCLUSIONS ICU admission solely for EVD care is costly. If safe EVD care can be provided outside of the ICU, it would represent a potential area for significant cost savings. Identifying appropriate patients for EVD care on the floor is multifactorial and requires vigilance in balancing the expenses associated with ICU utilization and optimal patient care.
Collapse
Affiliation(s)
- Jason K Chu
- 1Department of Neurosurgery, University of Southern California.,2Division of Neurosurgery, Department of Surgery, Children's Hospital of Los Angeles, Los Angeles, California; and
| | - Abdullah H Feroze
- 3Department of Neurosurgery, University of Washington School of Medicine, Seattle, Washington
| | - Kelly Collins
- 3Department of Neurosurgery, University of Washington School of Medicine, Seattle, Washington
| | - Lynn B McGrath
- 3Department of Neurosurgery, University of Washington School of Medicine, Seattle, Washington
| | - Christopher C Young
- 3Department of Neurosurgery, University of Washington School of Medicine, Seattle, Washington
| | - John R Williams
- 3Department of Neurosurgery, University of Washington School of Medicine, Seattle, Washington
| | - Samuel R Browd
- 3Department of Neurosurgery, University of Washington School of Medicine, Seattle, Washington
| |
Collapse
|
31
|
Simon TD, Kronman MP, Whitlock KB, Browd SR, Holubkov R, Kestle JRW, Kulkarni AV, Langley M, Limbrick DD, Luerssen TG, Oakes WJ, Riva-Cambrin J, Rozzelle C, Shannon CN, Tamber M, Wellons JC, Whitehead WE, Mayer-Hamblett N. Reinfection rates following adherence to Infectious Diseases Society of America guideline recommendations in first cerebrospinal fluid shunt infection treatment. J Neurosurg Pediatr 2019; 23:1-9. [PMID: 30771757 DOI: 10.3171/2018.11.peds18373] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/14/2018] [Accepted: 11/14/2018] [Indexed: 11/06/2022]
Abstract
OBJECTIVECSF shunt infection treatment requires both surgical and antibiotic decisions. Using the Hydrocephalus Clinical Research Network (HCRN) Registry and 2004 Infectious Diseases Society of America (IDSA) guidelines that were not proactively distributed to HCRN providers, the authors previously found high adherence to surgical recommendations but poor adherence to intravenous (IV) antibiotic duration recommendations. In general, IV antibiotic duration was longer than recommended. In March 2017, new IDSA guidelines expanded upon the 2004 guidelines by including recommendations for selection of specific antibiotics. The objective of this study was to describe adherence to both 2004 and 2017 IDSA guideline recommendations for CSF shunt infection treatment, and to report reinfection rates associated with adherence to guideline recommendations.METHODSThe authors investigated a prospective cohort of children younger than 18 years of age who underwent treatment for first CSF shunt infection at one of 7 hospitals from April 2008 to December 2012. CSF shunt infection was diagnosed by recovery of bacteria from CSF culture (CSF-positive infection). Adherence to 2004 and 2017 guideline recommendations was determined. Adherence to antibiotics was further classified as longer or shorter duration than guideline recommendations. Reinfection rates with 95% confidence intervals (CIs) were generated.RESULTSThere were 133 children with CSF-positive infections addressed by 2004 IDSA guideline recommendations, with 124 at risk for reinfection. Zero reinfections were observed among those whose treatment was fully adherent (0/14, 0% [95% CI 0%-20%]), and 15 reinfections were observed among those whose infection treatment was nonadherent (15/110, 14% [95% CI 8%-21%]). Among the 110 first infections whose infection treatment was nonadherent, 74 first infections were treated for a longer duration than guidelines recommended and 9 developed reinfection (9/74, 12% [95% CI 6%-22%]). There were 145 children with CSF-positive infections addressed by 2017 IDSA guideline recommendations, with 135 at risk for reinfection. No reinfections were observed among children whose treatment was fully adherent (0/3, 0% [95% CI 0%-64%]), and 18 reinfections were observed among those whose infection treatment was nonadherent (18/132, 14% [95% CI 8%-21%]).CONCLUSIONSThere is no clear evidence that either adherence to IDSA guidelines or duration of treatment longer than recommended is associated with reduction in reinfection rates. Because IDSA guidelines recommend shorter IV antibiotic durations than are typically used, improvement efforts to reduce IV antibiotic use in CSF shunt infection treatment can and should utilize IDSA guidelines.
Collapse
Affiliation(s)
- Tamara D Simon
- Departments of1Pediatrics and
- 2Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington
| | - Matthew P Kronman
- Departments of1Pediatrics and
- 2Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington
| | - Kathryn B Whitlock
- 2Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington
| | - Samuel R Browd
- 3Neurosurgery, University of Washington, Seattle Children's Hospital, Seattle
| | | | - John R W Kestle
- 5Division of Pediatric Neurosurgery, Primary Children's Medical Center, Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Abhaya V Kulkarni
- 6Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Marcie Langley
- 5Division of Pediatric Neurosurgery, Primary Children's Medical Center, Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - David D Limbrick
- 7Department of Neurosurgery, St. Louis Children's Hospital, Washington University in St. Louis, Missouri
| | - Thomas G Luerssen
- 8Division of Pediatric Neurosurgery, Texas Children's Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - W Jerry Oakes
- 9Section of Pediatric Neurosurgery, Children's Hospital of Alabama, Division of Neurosurgery, University of Alabama-Birmingham, Alabama; and
| | - Jay Riva-Cambrin
- 5Division of Pediatric Neurosurgery, Primary Children's Medical Center, Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Curtis Rozzelle
- 9Section of Pediatric Neurosurgery, Children's Hospital of Alabama, Division of Neurosurgery, University of Alabama-Birmingham, Alabama; and
| | - Chevis N Shannon
- 9Section of Pediatric Neurosurgery, Children's Hospital of Alabama, Division of Neurosurgery, University of Alabama-Birmingham, Alabama; and
| | - Mandeep Tamber
- 10Division of Neurosurgery, Children's Hospital of Pittsburgh, Pennsylvania
| | - John C Wellons
- 9Section of Pediatric Neurosurgery, Children's Hospital of Alabama, Division of Neurosurgery, University of Alabama-Birmingham, Alabama; and
| | - William E Whitehead
- 8Division of Pediatric Neurosurgery, Texas Children's Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - Nicole Mayer-Hamblett
- Departments of1Pediatrics and
- 2Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington
| |
Collapse
|
32
|
Alexiades NG, Ahn ES, Blount JP, Brockmeyer DL, Browd SR, Grant GA, Heuer GG, Hankinson TC, Iskandar BJ, Jea A, Krieger MD, Leonard JR, Limbrick DD, Maher CO, Proctor MR, Sandberg DI, Wellons JC, Shao B, Feldstein NA, Anderson RCE. Development of best practices to minimize wound complications after complex tethered spinal cord surgery: a modified Delphi study. J Neurosurg Pediatr 2018; 22:701-709. [PMID: 30215584 DOI: 10.3171/2018.6.peds18243] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/26/2018] [Accepted: 06/13/2018] [Indexed: 11/06/2022]
Abstract
OBJECTIVEComplications after complex tethered spinal cord (cTSC) surgery include infections and cerebrospinal fluid (CSF) leaks. With little empirical evidence to guide management, there is variability in the interventions undertaken to limit complications. Expert-based best practices may improve the care of patients undergoing cTSC surgery. Here, authors conducted a study to identify consensus-driven best practices.METHODSThe Delphi method was employed to identify consensual best practices. A literature review regarding cTSC surgery together with a survey of current practices was distributed to 17 board-certified pediatric neurosurgeons. Thirty statements were then formulated and distributed to the group. Results of the second survey were discussed during an in-person meeting leading to further consensus, which was defined as ≥ 80% agreement on a 4-point Likert scale (strongly agree, agree, disagree, strongly disagree).RESULTSSeventeen consensus-driven best practices were identified, with all participants willing to incorporate them into their practice. There were four preoperative interventions: (1, 2) asymptomatic AND symptomatic patients should be referred to urology preoperatively, (3, 4) routine preoperative urine cultures are not necessary for asymptomatic AND symptomatic patients. There were nine intraoperative interventions: (5) patients should receive perioperative cefazolin or an equivalent alternative in the event of allergy, (6) chlorhexidine-based skin preparation is the preferred regimen, (7) saline irrigation should be used intermittently throughout the case, (8) antibiotic-containing irrigation should be used following dural closure, (9) a nonlocking running suture technique should be used for dural closure, (10) dural graft overlay should be used when unable to obtain primary dural closure, (11) an expansile dural graft should be incorporated in cases of lipomyelomeningocele in which primary dural closure does not permit free flow of CSF, (12) paraxial muscles should be closed as a layer separate from the fascia, (13) routine placement of postoperative drains is not necessary. There were three postoperative interventions: (14) postoperative antibiotics are an option and, if given, should be discontinued within 24 hours; (15) patients should remain flat for at least 24 hours postoperatively; (16) routine use of abdominal binders or other compressive devices postoperatively is not necessary. One intervention was prioritized for additional study: (17) further study of additional gram-negative perioperative coverage is needed.CONCLUSIONSA modified Delphi technique was used to develop consensus-driven best practices for decreasing wound complications after cTSC surgery. Further study is required to determine if implementation of these practices will lead to reduced complications. Discussion through the course of this study resulted in the initiation of a multicenter study of gram-negative surgical site infections in cTSC surgery.
Collapse
Affiliation(s)
- Nikita G Alexiades
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York
| | - Edward S Ahn
- 2Department of Neurological Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Jeffrey P Blount
- 3Department of Neurosurgery, Division of Pediatric Neurosurgery, University of Alabama, Birmingham, Alabama
| | - Douglas L Brockmeyer
- 4Department of Pediatric Neurosurgery, Primary Children's Hospital, University of Utah, Salt Lake City, Utah
| | - Samuel R Browd
- 5Department of Neurosurgery, University of Washington Seattle Children's Hospital, Seattle, Washington
| | - Gerald A Grant
- 6Department of Neurosurgery, Stanford University, Stanford, California
| | - Gregory G Heuer
- 7Department of Neurosurgery, Children's Hospital of Philadelphia, Pennsylvania
| | - Todd C Hankinson
- 8Department of Pediatric Neurosurgery, Children's Hospital Colorado, Anschutz Medical Campus, Aurora, Colorado
| | - Bermans J Iskandar
- 9Department of Neurosurgery, University of Wisconsin Hospitals and Clinics, Madison, Wisconsin
| | - Andrew Jea
- 10Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana
| | - Mark D Krieger
- 11Department of Neurological Surgery, USC Keck School of Medicine/Children's Hospital of Los Angeles, California
| | - Jeffrey R Leonard
- 12Department of Neurosurgery, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio
| | - David D Limbrick
- 13Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri
| | - Cormac O Maher
- 14Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan
| | - Mark R Proctor
- 15Department of Neurosurgery, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
| | - David I Sandberg
- 16Department of Neurosurgery, McGovern Medical School/University of Texas Health Science Center, Houston, Texas
| | - John C Wellons
- 17Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee; and
| | - Belinda Shao
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York.,18Rutgers New Jersey Medical School, Newark, New Jersey
| | - Neil A Feldstein
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York
| | - Richard C E Anderson
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York
| |
Collapse
|
33
|
Simon TD, Kronman MP, Whitlock KB, Browd SR, Holubkov R, Kestle JRW, Kulkarni AV, Langley M, Limbrick DD, Luerssen TG, Oakes J, Riva-Cambrin J, Rozzelle C, Shannon CN, Tamber M, Wellons III JC, Whitehead WE, Mayer-Hamblett N. Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection. J Pediatric Infect Dis Soc 2018; 8:235-243. [PMID: 29771360 PMCID: PMC6601384 DOI: 10.1093/jpids/piy035] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
BACKGROUND Previous studies of cerebrospinal fluid (CSF) shunt infection treatment have been limited in size and unable to compare patient and treatment characteristics by infecting organism. Our objective was to describe variation in patient and treatment characteristics for children with first CSF shunt infection, stratified by infecting organism subgroups outlined in the 2017 Infectious Disease Society of America's (IDSA) guidelines. METHODS We studied a prospective cohort of children <18 years of age undergoing treatment for first CSF shunt infection at one of 7 Hydrocephalus Clinical Research Network hospitals from April 2008 to December 2012. Differences between infecting organism subgroups were described using univariate analyses and Fisher's exact tests. RESULTS There were 145 children whose infections were diagnosed by CSF culture and addressed by IDSA guidelines, including 47 with Staphylococcus aureus, 52 with coagulase-negative Staphylococcus, 37 with Gram-negative bacilli, and 9 with Propionibacterium acnes. No differences in many patient and treatment characteristics were seen between infecting organism subgroups, including age at initial shunt, gender, race, insurance, indication for shunt, gastrostomy, tracheostomy, ultrasound, and/or endoscope use at all surgeries before infection, or numbers of revisions before infection. A larger proportion of infections were caused by Gram-negative bacilli when antibiotic-impregnated catheters were used at initial shunt placement (12 of 23, 52%) and/or subsequent revisions (11 of 23, 48%) compared with all other infections (9 of 68 [13%] and 13 of 68 [19%], respectively). No differences in reinfection were observed between infecting organism subgroups. CONCLUSIONS The organism profile encountered at infection differs when antibiotic-impregnated catheters are used, with a higher proportion of Gram-negative bacilli. This warrants further investigation given increasing adoption of antibiotic-impregnated catheters.
Collapse
Affiliation(s)
- Tamara D Simon
- Department of Pediatrics, University of Washington/Seattle Children’s Hospital, Washington,Seattle Children’s Research Institute, Washington,Correspondence: T. Simon, MD, MSPH, Associate Professor, University of Washington Department of Pediatrics, Division of Hospital Medicine, Seattle Children’s Research Institute Building 1, M/S JMB9, 1900 Ninth Avenue, Seattle, WA 98101 ()
| | - Matthew P Kronman
- Department of Pediatrics, University of Washington/Seattle Children’s Hospital, Washington,Seattle Children’s Research Institute, Washington
| | | | - Samuel R Browd
- Department of Neurosurgery, University of Washington/Seattle Children’s Hospital, Washington
| | | | - John R W Kestle
- Division of Pediatric Neurosurgery, Department of Neurosurgery, University of Utah, Salt Lake City
| | - Abhaya V Kulkarni
- Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Canada
| | - Marcie Langley
- Division of Pediatric Neurosurgery, Department of Neurosurgery, University of Utah, Salt Lake City
| | - David D Limbrick
- Department of Neurosurgery, St. Louis Children’s Hospital, Washington University in St. Louis, Missouri
| | - Thomas G Luerssen
- Division of Pediatric Neurosurgery, Texas Children’s Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston
| | - Jerry Oakes
- Section of Pediatric Neurosurgery, Children’s Hospital of Alabama, Division of Neurosurgery, University of Alabama – Birmingham
| | - Jay Riva-Cambrin
- Division of Pediatric Neurosurgery, Department of Neurosurgery, University of Utah, Salt Lake City,Present Affiliation: Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta
| | - Curtis Rozzelle
- Section of Pediatric Neurosurgery, Children’s Hospital of Alabama, Division of Neurosurgery, University of Alabama – Birmingham
| | - Chevis N Shannon
- Section of Pediatric Neurosurgery, Children’s Hospital of Alabama, Division of Neurosurgery, University of Alabama – Birmingham,Present Affiliation: Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Mandeep Tamber
- Division of Neurosurgery, Children’s Hospital of Pittsburgh, Pennsylvania
| | - John C Wellons III
- Section of Pediatric Neurosurgery, Children’s Hospital of Alabama, Division of Neurosurgery, University of Alabama – Birmingham,Present Affiliation: Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - William E Whitehead
- Division of Pediatric Neurosurgery, Texas Children’s Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston
| | - Nicole Mayer-Hamblett
- Department of Pediatrics, University of Washington/Seattle Children’s Hospital, Washington,Department of Neurosurgery, University of Washington/Seattle Children’s Hospital, Washington
| | | |
Collapse
|
34
|
Simon TD, Kronman MP, Whitlock KB, Gove NE, Mayer-Hamblett N, Browd SR, Cochrane DD, Holubkov R, Kulkarni AV, Langley M, Limbrick DD, Luerssen TG, Oakes WJ, Riva-Cambrin J, Rozzelle C, Shannon C, Tamber M, Wellons JC, Whitehead WE, Kestle JRW. Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study. J Neurosurg Pediatr 2018; 21:346-358. [PMID: 29393813 PMCID: PMC5880734 DOI: 10.3171/2017.9.peds17112] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE CSF shunt infection requires both surgical and antibiotic treatment. Surgical treatment includes either total shunt removal with external ventricular drain (EVD) placement followed by new shunt insertion, or distal shunt externalization followed by new shunt insertion once the CSF is sterile. Antibiotic treatment includes the administration of intravenous antibiotics. The Hydrocephalus Clinical Research Network (HCRN) registry provides a unique opportunity to understand reinfection following treatment for CSF shunt infection. This study examines the association of surgical and antibiotic decisions in the treatment of first CSF shunt infection with reinfection. METHODS A prospective cohort study of children undergoing treatment for first CSF infection at 7 HCRN hospitals from April 2008 to December 2012 was performed. The HCRN consensus definition was used to define CSF shunt infection and reinfection. The key surgical predictor variable was surgical approach to treatment for CSF shunt infection, and the key antibiotic treatment predictor variable was intravenous antibiotic selection and duration. Cox proportional hazards models were constructed to address the time-varying nature of the characteristics associated with shunt surgeries. RESULTS Of 233 children in the HCRN registry with an initial CSF shunt infection during the study period, 38 patients (16%) developed reinfection over a median time of 44 days (interquartile range [IQR] 19-437). The majority of initial CSF shunt infections were treated with total shunt removal and EVD placement (175 patients; 75%). The median time between infection surgeries was 15 days (IQR 10-22). For the subset of 172 infections diagnosed by CSF culture, the mean ± SD duration of antibiotic treatment was 18.7 ± 12.8 days. In all Cox proportional hazards models, neither surgical approach to infection treatment nor overall intravenous antibiotic duration was independently associated with reinfection. The only treatment decision independently associated with decreased infection risk was the use of rifampin. While this finding did not achieve statistical significance, in all 5 Cox proportional hazards models both surgical approach (other than total shunt removal at initial CSF shunt infection) and nonventriculoperitoneal shunt location were consistently associated with a higher hazard of reinfection, while the use of ultrasound was consistently associated with a lower hazard of reinfection. CONCLUSIONS Neither surgical approach to treatment nor antibiotic duration was associated with reinfection risk. While these findings did not achieve statistical significance, surgical approach other than total removal at initial CSF shunt infection was consistently associated with a higher hazard of reinfection in this study and suggests the feasibility of controlling and standardizing the surgical approach (shunt removal with EVD placement). Considerably more variation and equipoise exists in the duration and selection of intravenous antibiotic treatment. Further consideration should be given to the use of rifampin in the treatment of CSF shunt infection. High-quality studies of the optimal duration of antibiotic treatment are critical to the creation of evidence-based guidelines for CSF shunt infection treatment.
Collapse
Affiliation(s)
- Tamara D. Simon
- Department of Pediatrics, University of Washington/Seattle Children's Hospital,Seattle Children's Research Institute, Seattle, Washington
| | - Matthew P. Kronman
- Department of Pediatrics, University of Washington/Seattle Children's Hospital,Seattle Children's Research Institute, Seattle, Washington
| | | | - Nancy E. Gove
- Seattle Children's Research Institute, Seattle, Washington
| | - Nicole Mayer-Hamblett
- Department of Pediatrics, University of Washington/Seattle Children's Hospital,Seattle Children's Research Institute, Seattle, Washington
| | - Samuel R. Browd
- Department of Neurosurgery, University of Washington/Seattle Children's Hospital
| | - D. Douglas Cochrane
- Division of Neurosurgery, The Hospital for Sick Children, University of Toronto, Ontario, Canada
| | | | - Abhaya V. Kulkarni
- Division of Neurosurgery, The Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Marcie Langley
- Division of Pediatric Neurosurgery, Primary Children's Hospital, Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - David D. Limbrick
- Department of Neurosurgery, St. Louis Children's Hospital, Washington University in St. Louis, Missouri
| | - Thomas G. Luerssen
- Division of Pediatric Neurosurgery, Texas Children's Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - W. Jerry Oakes
- Section of Pediatric Neurosurgery, Children's of Alabama, Division of Neurosurgery, University of Alabama at Birmingham, Alabama
| | - Jay Riva-Cambrin
- Department of Clinical Neurosciences, University of Calgary, Alberta, Canada
| | - Curtis Rozzelle
- Section of Pediatric Neurosurgery, Children's of Alabama, Division of Neurosurgery, University of Alabama at Birmingham, Alabama
| | - Chevis Shannon
- Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Mandeep Tamber
- Division of Neurosurgery, Children's Hospital of Pittsburgh, Pennsylvania
| | - John C. Wellons
- Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - William E. Whitehead
- Division of Pediatric Neurosurgery, Texas Children's Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - John R. W. Kestle
- Division of Pediatric Neurosurgery, Primary Children's Hospital, Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| |
Collapse
|
35
|
Kulkarni AV, Riva-Cambrin J, Rozzelle CJ, Naftel RP, Alvey JS, Reeder RW, Holubkov R, Browd SR, Cochrane DD, Limbrick DD, Simon TD, Tamber M, Wellons JC, Whitehead WE, Kestle JRW. Endoscopic third ventriculostomy and choroid plexus cauterization in infant hydrocephalus: a prospective study by the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 2018; 21:214-223. [PMID: 29243972 DOI: 10.3171/2017.8.peds17217] [Citation(s) in RCA: 47] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE High-quality data comparing endoscopic third ventriculostomy (ETV) with choroid plexus cauterization (CPC) to shunt and ETV alone in North America are greatly lacking. To address this, the Hydrocephalus Clinical Research Network (HCRN) conducted a prospective study of ETV+CPC in infants. Here, these prospective data are presented and compared to prospectively collected data from a historical cohort of infants treated with shunt or ETV alone. METHODS From June 2014 to September 2015, infants (corrected age ≤ 24 months) requiring treatment for hydrocephalus with anatomy suitable for ETV+CPC were entered into a prospective study at 9 HCRN centers. The rate of procedural failure (i.e., the need for repeat hydrocephalus surgery, hydrocephalus-related death, or major postoperative neurological deficit) was determined. These data were compared with a cohort of similar infants who were treated with either a shunt (n = 969) or ETV alone (n = 74) by creating matched pairs on the basis of age and etiology. These data were obtained from the existing prospective HCRN Core Data Project. All patients were observed for at least 6 months. RESULTS A total of 118 infants underwent ETV+CPC (median corrected age 1.3 months; common etiologies including myelomeningocele [30.5%], intraventricular hemorrhage of prematurity [22.9%], and aqueductal stenosis [21.2%]). The 6-month success rate was 36%. The most common complications included seizures (5.1%) and CSF leak (3.4%). Important predictors of treatment success in the survival regression model included older age (p = 0.002), smaller preoperative ventricle size (p = 0.009), and greater degree of CPC (p = 0.02). The matching algorithm resulted in 112 matched pairs for ETV+CPC versus shunt alone and 34 matched pairs for ETV+CPC versus ETV alone. ETV+CPC was found to have significantly higher failure rate than shunt placement (p < 0.001). Although ETV+CPC had a similar failure rate compared with ETV alone (p = 0.73), the matched pairs included mostly infants with aqueductal stenosis and miscellaneous other etiologies but very few patients with intraventricular hemorrhage of prematurity. CONCLUSIONS Within a large and broad cohort of North American infants, our data show that overall ETV+CPC appears to have a higher failure rate than shunt alone. Although the ETV+CPC results were similar to ETV alone, this comparison was limited by the small sample size and skewed etiological distribution. Within the ETV+CPC group, greater extent of CPC was associated with treatment success, thereby suggesting that there are subgroups who might benefit from the addition of CPC. Further work will focus on identifying these subgroups.
Collapse
Affiliation(s)
- Abhaya V Kulkarni
- 1Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - Jay Riva-Cambrin
- 2Section of Neurosurgery, Alberta Children's Hospital, University of Calgary, Alberta, Canada
| | - Curtis J Rozzelle
- 3Department of Neurosurgery, Division of Pediatric Neurosurgery, The University of Alabama at Birmingham and Children's Hospital of Alabama, Birmingham, Alabama
| | - Robert P Naftel
- 4Department of Neurological Surgery, Vanderbilt University, Nashville, Tennessee
| | | | | | | | | | - D Douglas Cochrane
- 1Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - David D Limbrick
- 7Department of Neurological Surgery, St. Louis Children's Hospital, St. Louis, Missouri
| | - Tamara D Simon
- 8Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington
| | - Mandeep Tamber
- 9Department of Neurological Surgery, Pittsburgh Children's Hospital, Pittsburgh, Pennsylvania; and
| | - John C Wellons
- 4Department of Neurological Surgery, Vanderbilt University, Nashville, Tennessee
| | | | - John R W Kestle
- 11Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| |
Collapse
|
36
|
Affiliation(s)
- Peter A Chiarelli
- Department of Neurosurgery, Seattle Children's Hospital, Seattle, Washington.,Department of Neurological Surgery, University of Washington, Seattle
| | - Jason S Hauptman
- Department of Neurosurgery, Seattle Children's Hospital, Seattle, Washington.,Department of Neurological Surgery, University of Washington, Seattle
| | - Samuel R Browd
- Department of Neurosurgery, Seattle Children's Hospital, Seattle, Washington.,Department of Neurological Surgery, University of Washington, Seattle
| |
Collapse
|
37
|
Wang AC, Ibrahim GM, Poliakov AV, Wang PI, Fallah A, Mathern GW, Buckley RT, Collins K, Weil AG, Shurtleff HA, Warner MH, Perez FA, Shaw DW, Wright JN, Saneto RP, Novotny EJ, Lee A, Browd SR, Ojemann JG. Corticospinal tract atrophy and motor fMRI predict motor preservation after functional cerebral hemispherectomy. J Neurosurg Pediatr 2018; 21:81-89. [PMID: 29099351 DOI: 10.3171/2017.7.peds17137] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE The potential loss of motor function after cerebral hemispherectomy is a common cause of anguish for patients, their families, and their physicians. The deficits these patients face are individually unique, but as a whole they provide a framework to understand the mechanisms underlying cortical reorganization of motor function. This study investigated whether preoperative functional MRI (fMRI) and diffusion tensor imaging (DTI) could predict the postoperative preservation of hand motor function. METHODS Thirteen independent reviewers analyzed sensorimotor fMRI and colored fractional anisotropy (CoFA)-DTI maps in 25 patients undergoing functional hemispherectomy for treatment of intractable seizures. Pre- and postoperative gross hand motor function were categorized and correlated with fMRI and DTI findings, specifically, abnormally located motor activation on fMRI and corticospinal tract atrophy on DTI. RESULTS Normal sensorimotor cortical activation on preoperative fMRI was significantly associated with severe decline in postoperative motor function, demonstrating 92.9% sensitivity (95% CI 0.661-0.998) and 100% specificity (95% CI 0.715-1.00). Bilaterally robust, symmetric corticospinal tracts on CoFA-DTI maps were significantly associated with severe postoperative motor decline, demonstrating 85.7% sensitivity (95% CI 0.572-0.982) and 100% specificity (95% CI 0.715-1.00). Interpreting the fMR images, the reviewers achieved a Fleiss' kappa coefficient (κ) for interrater agreement of κ = 0.69, indicating good agreement (p < 0.01). When interpreting the CoFA-DTI maps, the reviewers achieved κ = 0.64, again indicating good agreement (p < 0.01). CONCLUSIONS Functional hemispherectomy offers a high potential for seizure freedom without debilitating functional deficits in certain instances. Patients likely to retain preoperative motor function can be identified prior to hemispherectomy, where fMRI or DTI suggests that cortical reorganization of motor function has occurred prior to the operation.
Collapse
Affiliation(s)
| | - George M Ibrahim
- 3Division of Neurosurgery, Hospital for Sick Children and Toronto Western Hospital, Toronto, Ontario, Canada; Departments of
| | | | | | | | - Gary W Mathern
- Departments of1Neurosurgery and.,2Psychiatry and BioBehavioral Sciences, The Brain Research Institute, University of California, Los Angeles, California
| | | | | | - Alexander G Weil
- 7Division of Pediatric Neurosurgery, Department of Surgery, Sainte Justine Hospital, University of Montreal, Quebec, Canada
| | | | | | - Francisco A Perez
- 6Radiology, University of Washington, Seattle Children's Hospital, Seattle, Washington; and
| | - Dennis W Shaw
- 6Radiology, University of Washington, Seattle Children's Hospital, Seattle, Washington; and
| | - Jason N Wright
- 6Radiology, University of Washington, Seattle Children's Hospital, Seattle, Washington; and
| | | | | | | | | | | |
Collapse
|
38
|
Bonow RH, Friedman SD, Perez FA, Ellenbogen RG, Browd SR, Mac Donald CL, Vavilala MS, Rivara FP. Prevalence of Abnormal Magnetic Resonance Imaging Findings in Children with Persistent Symptoms after Pediatric Sports-Related Concussion. J Neurotrauma 2017; 34:2706-2712. [PMID: 28490224 DOI: 10.1089/neu.2017.4970] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
A subset of patients experience persistent symptoms after pediatric concussion, and magnetic resonance imaging (MRI) is commonly used to evaluate for pathology. The utility of this practice is unclear. We conducted a retrospective cohort study to describe the MRI findings in children with concussion. A registry of all patients seen at our institution from January 2010 through March 2016 with pediatric sports-related concussion was cross-referenced with a database of radiographical studies. Radiology reports were reviewed for abnormal findings. Patients with abnormal computed tomographies or MRI scans ordered for reasons other than concussion were excluded. Among 3338 children identified with concussion, 427 underwent MRI. Only 2 (0.5%) had findings compatible with traumatic injury, consisting in both of microhemorrhage. Sixty-one patients (14.3%) had abnormal findings unrelated to trauma, including 24 nonspecific T2 changes, 15 pineal cysts, eight Chiari I malformations, and five arachnoid cysts. One child underwent craniotomy for a cerebellar hemangioblastoma after presenting with ataxia; another had cortical dysplasia resected after seizure. The 2 patients with microhemorrhage each had three previous concussions, significantly more than patients whose scans were normal (median, 1) or abnormal without injury (median, 1.5; p = 0.048). MRI rarely revealed intracranial injuries in children post-concussion, and the clinical relevance of these uncommon findings remains unclear. Abnormalities unrelated to trauma are usually benign. However, MRI should be thoughtfully considered in children who present with concerning or atypical symptoms.
Collapse
Affiliation(s)
- Robert H Bonow
- 1 Harborview Injury Prevention Research Center, Harborview Medical Center, University of Washington , Seattle, Washington.,2 Department of Neurological Surgery, University of Washington , and Seattle Children's Hospital, Seattle, Washington
| | - Seth D Friedman
- 3 Radiology Clinical Research Imaging Core, Center for Clinical and Translational Research , Seattle Children's Hospital, Seattle, Washington
| | - Francisco A Perez
- 4 Department of Radiology, Seattle Children's Hospital, University of Washington , and Seattle Children's Hospital, Seattle, Washington
| | - Richard G Ellenbogen
- 2 Department of Neurological Surgery, University of Washington , and Seattle Children's Hospital, Seattle, Washington
| | - Samuel R Browd
- 2 Department of Neurological Surgery, University of Washington , and Seattle Children's Hospital, Seattle, Washington
| | - Christine L Mac Donald
- 2 Department of Neurological Surgery, University of Washington , and Seattle Children's Hospital, Seattle, Washington
| | - Monica S Vavilala
- 1 Harborview Injury Prevention Research Center, Harborview Medical Center, University of Washington , Seattle, Washington.,5 Department of Anesthesia & Pain Medicine, Harborview Medical Center, University of Washington , Seattle, Washington
| | - Frederick P Rivara
- 1 Harborview Injury Prevention Research Center, Harborview Medical Center, University of Washington , Seattle, Washington.,6 Department of Pediatrics, Seattle Children's Hospital, University of Washington , and Seattle Children's Hospital, Seattle, Washington
| |
Collapse
|
39
|
Hanak BW, Hsieh CY, Donaldson W, Browd SR, Lau KKS, Shain W. Reduced cell attachment to poly(2-hydroxyethyl methacrylate)-coated ventricular catheters in vitro. J Biomed Mater Res B Appl Biomater 2017. [PMID: 28631360 DOI: 10.1002/jbm.b.33915] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
The majority of patients with hydrocephalus are dependent on ventriculoperitoneal shunts for diversion of excess cerebrospinal fluid. Unfortunately, these shunts are failure-prone and over half of all life-threatening pediatric failures are caused by obstruction of the ventricular catheter by the brain's resident immune cells, reactive microglia and astrocytes. Poly(2-hydroxyethyl methacrylate) (PHEMA) hydrogels are widely used for biomedical implants. The extreme hydrophilicity of PHEMA confers resistance to protein fouling, making it a strong candidate coating for ventricular catheters. With the advent of initiated chemical vapor deposition (iCVD), a solvent-free coating technology that creates a polymer in thin film form on a substrate surface by introducing gaseous reactant species into a vacuum reactor, it is now possible to apply uniform polymer coatings on complex three-dimensional substrate surfaces. iCVD was utilized to coat commercially available ventricular catheters with PHEMA. The chemical structure was confirmed on catheter surfaces using Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy. PHEMA coating morphology was characterized by scanning electron microscopy. Testing PHEMA-coated catheters against uncoated clinical-grade catheters in an in vitro hydrocephalus catheter bioreactor containing co-cultured astrocytes and microglia revealed significant reductions in cell attachment to PHEMA-coated catheters at both 17-day and 6-week time points. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1268-1279, 2018.
Collapse
Affiliation(s)
- Brian W Hanak
- Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Chia-Yun Hsieh
- Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania
| | - William Donaldson
- Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
| | - Samuel R Browd
- Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington.,Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Kenneth K S Lau
- Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania
| | - William Shain
- Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington
| |
Collapse
|
40
|
Abstract
Although cerebrospinal fluid (CSF) shunt placement is the most common procedure performed by pediatric neurosurgeons, shunts remain among the most failure-prone life-sustaining medical devices implanted in modern medical practice. This article provides an overview of the mechanisms of CSF shunt failure for the 3 most commonly employed definitive CSF shunts in the practice of pediatric neurosurgery: ventriculoperitoneal, ventriculopleural, and ventriculoatrial. The text has been partitioned into the broad modes of shunt failure: obstruction, infection, mechanical shunt failure, overdrainage, and distal catheter site-specific failures. Clinical management strategies for the various modes of shunt failure are discussed as are research efforts directed towards reducing shunt complication rates. As it is unlikely that CSF shunting will become an obsolete procedure in the foreseeable future, it is incumbent on the pediatric neurosurgery community to maintain focused efforts to improve our understanding of and management strategies for shunt failure and shunt-related morbidity.
Collapse
Affiliation(s)
- Brian W. Hanak
- Department of Neurological Surgery, University of Washington and Seattle Children’s Hospital, Seattle, WA
| | - Robert H. Bonow
- Department of Neurological Surgery, University of Washington and Seattle Children’s Hospital, Seattle, WA
| | - Carolyn A. Harris
- Department of Neurosurgery, Wayne State University and Children’s Hospital of Michigan, Detroit, MI, USA
| | - Samuel R. Browd
- Department of Neurological Surgery, University of Washington and Seattle Children’s Hospital, Seattle, WA
| |
Collapse
|
41
|
Hanak BW, Tomycz L, Oxford RG, Hooper E, Apkon SD, Browd SR. An algorithmic approach to the management of unrecognized hydrocephalus in pediatric candidates for intrathecal baclofen pump implantation. Surg Neurol Int 2017; 7:105. [PMID: 28168091 PMCID: PMC5223398 DOI: 10.4103/2152-7806.196236] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2015] [Accepted: 08/21/2016] [Indexed: 11/04/2022] Open
Abstract
BACKGROUND Complications of intrathecal baclofen (ITB) pump implantation for treatment of pediatric patients with spasticity and dystonia associated with cerebral palsy remain unacceptably high. To address the concern that some patients may have underlying arrested hydrocephalus, which is difficult to detect clinically because of a low baseline level of neurological function, and may contribute to the high rates of postoperative cerebrospinal fluid leak, wound breakdown, and infection associated with ITB pump implantation, the authors implemented a standardized protocol including mandatory cranial imaging and assessment of intracranial pressure (ICP) by lumbar puncture prior to ITB pump implantation. METHODS A retrospective case series of patients considered for ITB pump implantation between September 2012 and October 2014 at Seattle Children's Hospital is presented. All patients underwent lumbar puncture under general anesthesia prior to ITB pump implantation and, if the opening pressure was greater than 21 cmH2O, ITB pump implantation was aborted and alternative management options were presented to the patient's family. RESULTS Eighteen patients were treated during the study time period. Eight patients (44.4%) who had ICPs in excess of 21 cmH2O on initial LP were identified. Eleven patients (61.1%) ultimately underwent ITB pump implantation (9/10 in the "normal ICP" group and 2/8 in the "elevated ICP" group following ventriculoperitoneal shunt placement), without any postoperative complications. CONCLUSIONS Given the potentially high rate of elevated ICP and arrested hydrocephalus, the authors advocate pre-implantation assessment of ICP under controlled conditions and a thoughtful consideration of the neurosurgical management options for patients with elevated ICP.
Collapse
Affiliation(s)
- Brian W Hanak
- Department of Neurological Surgery, Harborview Medical Center, UW Medicine, Seattle, Washington, USA
| | - Luke Tomycz
- Department of Neurosurgery, Dell Children's Medical Center, Austin, Texas, USA
| | - Robert G Oxford
- Department of Neurological Surgery, Harborview Medical Center, UW Medicine, Seattle, Washington, USA
| | - Erin Hooper
- Department of Rehabilitation Medicine, Seattle Children's Hospital, Seattle, Washington, USA
| | - Susan D Apkon
- Department of Rehabilitation Medicine, Seattle Children's Hospital, Seattle, Washington, USA
| | - Samuel R Browd
- Department of Neurosurgery, Seattle Children's Hospital, Seattle, Washington, USA
| |
Collapse
|
42
|
Whitehead WE, Riva-Cambrin J, Kulkarni AV, Wellons JC, Rozzelle CJ, Tamber MS, Limbrick DD, Browd SR, Naftel RP, Shannon CN, Simon TD, Holubkov R, Illner A, Cochrane DD, Drake JM, Luerssen TG, Oakes WJ, Kestle JRW. Ventricular catheter entry site and not catheter tip location predicts shunt survival: a secondary analysis of 3 large pediatric hydrocephalus studies. J Neurosurg Pediatr 2017; 19:157-167. [PMID: 27813457 DOI: 10.3171/2016.8.peds16229] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Accurate placement of ventricular catheters may result in prolonged shunt survival, but the best target for the hole-bearing segment of the catheter has not been rigorously defined. The goal of the study was to define a target within the ventricle with the lowest risk of shunt failure. METHODS Five catheter placement variables (ventricular catheter tip location, ventricular catheter tip environment, relationship to choroid plexus, catheter tip holes within ventricle, and crosses midline) were defined, assessed for interobserver agreement, and evaluated for their effect on shunt survival in univariate and multivariate analyses. De-identified subjects from the Shunt Design Trial, the Endoscopic Shunt Insertion Trial, and a Hydrocephalus Clinical Research Network study on ultrasound-guided catheter placement were combined (n = 858 subjects, all first-time shunt insertions, all patients < 18 years old). The first postoperative brain imaging study was used to determine ventricular catheter placement for each of the catheter placement variables. RESULTS Ventricular catheter tip location, environment, catheter tip holes within the ventricle, and crosses midline all achieved sufficient interobserver agreement (κ > 0.60). In the univariate survival analysis, however, only ventricular catheter tip location was useful in distinguishing a target within the ventricle with a survival advantage (frontal horn; log-rank, p = 0.0015). None of the other catheter placement variables yielded a significant survival advantage unless they were compared with catheter tips completely not in the ventricle. Cox regression analysis was performed, examining ventricular catheter tip location with age, etiology, surgeon, decade of surgery, and catheter entry site (anterior vs posterior). Only age (p < 0.001) and entry site (p = 0.005) were associated with shunt survival; ventricular catheter tip location was not (p = 0.37). Anterior entry site lowered the risk of shunt failure compared with posterior entry site by approximately one-third (HR 0.65, 95% CI 0.51-0.83). CONCLUSIONS This analysis failed to identify an ideal target within the ventricle for the ventricular catheter tip. Unexpectedly, the choice of an anterior versus posterior catheter entry site was more important in determining shunt survival than the location of the ventricular catheter tip within the ventricle. Entry site may represent a modifiable risk factor for shunt failure, but, due to inherent limitations in study design and previous clinical research on entry site, a randomized controlled trial is necessary before treatment recommendations can be made.
Collapse
Affiliation(s)
| | - Jay Riva-Cambrin
- Division of Neurosurgery, University of Calgary, Alberta, Canada
| | | | - John C Wellons
- Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Curtis J Rozzelle
- Department of Neurosurgery, University of Alabama at Birmingham, Alabama
| | - Mandeep S Tamber
- Department of Neurosurgery, University of Pittsburgh, Pennsylvania
| | - David D Limbrick
- Department of Neurosurgery, Washington University, St. Louis, Missouri
| | | | - Robert P Naftel
- Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Chevis N Shannon
- Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Tamara D Simon
- Pediatrics, University of Washington, Seattle, Washington
| | - Richard Holubkov
- Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Anna Illner
- Department of Radiology, Baylor College of Medicine, Houston, Texas; and
| | | | - James M Drake
- Division of Neurosurgery, University of Toronto, Ontario, Canada
| | - Thomas G Luerssen
- Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - W Jerry Oakes
- Department of Neurosurgery, University of Alabama at Birmingham, Alabama
| | - John R W Kestle
- Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | | |
Collapse
|
43
|
Simon TD, Kronman MP, Whitlock KB, Gove N, Browd SR, Holubkov R, Kestle JR, Kulkarni AV, Langley M, Limbrick DD, Luerssen TG, Oakes J, Riva-Cambrin J, Rozzelle C, Shannon C, Tamber M, Wellons JC, Whitehead WE, Mayer-Hamblett N. Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study. J Pediatr 2016; 179:185-191.e2. [PMID: 27692463 PMCID: PMC5123958 DOI: 10.1016/j.jpeds.2016.08.094] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/07/2016] [Revised: 08/15/2016] [Accepted: 08/26/2016] [Indexed: 11/16/2022]
Abstract
OBJECTIVES To describe the variation in approaches to surgical and antibiotic treatment for first cerebrospinal fluid (CSF) shunt infection and adherence to Infectious Diseases Society of America (IDSA) guidelines. STUDY DESIGN We conducted a prospective cohort study of children undergoing treatment for first CSF infection at 7 Hydrocephalus Clinical Research Network hospitals from April 2008 through December 2012. Univariate analyses were performed to describe the study population. RESULTS A total of 151 children underwent treatment for first CSF shunt-related infection. Most children had undergone initial CSF shunt placement before the age of 6 months (n = 98, 65%). Median time to infection after shunt surgery was 28 days (IQR 15-52 days). Surgical management was most often shunt removal with interim external ventricular drain placement, followed by new shunt insertion (n = 122, 81%). Median time from first negative CSF culture to final surgical procedure was 14 days (IQR 10-21 days). Median duration of intravenous (IV) antibiotic use duration was 19 days (IQR 12-28 days). For 84 infections addressed by IDSA guidelines, 7 (8%) met guidelines and 61 (73%) had longer duration of IV antibiotic use than recommended. CONCLUSIONS Surgical treatment for infection frequently adheres to IDSA guidelines of shunt removal with external ventricular drain placement followed by new shunt insertion. However, duration of IV antibiotic use in CSF shunt infection treatment was consistently longer than recommended by the 2004 IDSA guidelines.
Collapse
Affiliation(s)
- Tamara D. Simon
- Department of Pediatrics, University of Washington/Seattle Children’s Hospital, Seattle, Washington,Center for Clinical and Translational Research, Seattle Children’s Research Institute, Seattle, Washington
| | - Matthew P. Kronman
- Department of Pediatrics, University of Washington/Seattle Children’s Hospital, Seattle, Washington,Center for Clinical and Translational Research, Seattle Children’s Research Institute, Seattle, Washington
| | - Kathryn B. Whitlock
- Center for Clinical and Translational Research, Seattle Children’s Research Institute, Seattle, Washington
| | - Nancy Gove
- Center for Clinical and Translational Research, Seattle Children’s Research Institute, Seattle, Washington
| | - Samuel R. Browd
- Department of Neurosurgery, University of Washington/Seattle Children’s Hospital, Seattle, Washington
| | - Richard Holubkov
- Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - John R.W. Kestle
- Division of Pediatric Neurosurgery, Primary Children’s Medical Center, Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Abhaya V. Kulkarni
- Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - Marcie Langley
- Division of Pediatric Neurosurgery, Primary Children’s Medical Center, Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - David D. Limbrick
- Department of Neurosurgery, St. Louis Children’s Hospital, Washington University in Saint Louis, St. Louis, Missouri
| | - Thomas G. Luerssen
- Division of Pediatric Neurosurgery, Texas Children’s Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - Jerry Oakes
- Section of Pediatric Neurosurgery, Children’s Hospital of Alabama, Division of Neurosurgery, University of Alabama – Birmingham, Birmingham, Alabama
| | - Jay Riva-Cambrin
- Division of Pediatric Neurosurgery, Primary Children’s Medical Center, Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Curtis Rozzelle
- Section of Pediatric Neurosurgery, Children’s Hospital of Alabama, Division of Neurosurgery, University of Alabama – Birmingham, Birmingham, Alabama
| | - Chevis Shannon
- Section of Pediatric Neurosurgery, Children’s Hospital of Alabama, Division of Neurosurgery, University of Alabama – Birmingham, Birmingham, Alabama
| | - Mandeep Tamber
- Division of Neurosurgery, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
| | - John C. Wellons
- Section of Pediatric Neurosurgery, Children’s Hospital of Alabama, Division of Neurosurgery, University of Alabama – Birmingham, Birmingham, Alabama
| | - William E. Whitehead
- Division of Pediatric Neurosurgery, Texas Children’s Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - Nicole Mayer-Hamblett
- Department of Pediatrics, University of Washington/Seattle Children’s Hospital, Seattle, Washington,Center for Clinical and Translational Research, Seattle Children’s Research Institute, Seattle, Washington
| | | |
Collapse
|
44
|
Kulkarni AV, Riva-Cambrin J, Holubkov R, Browd SR, Cochrane DD, Drake JM, Limbrick DD, Rozzelle CJ, Simon TD, Tamber MS, Wellons JC, Whitehead WE, Kestle JRW. Endoscopic third ventriculostomy in children: prospective, multicenter results from the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 2016; 18:423-429. [PMID: 27258593 DOI: 10.3171/2016.4.peds163] [Citation(s) in RCA: 74] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
OBJECTIVE Endoscopic third ventriculostomy (ETV) is now established as a viable treatment option for a subgroup of children with hydrocephalus. Here, the authors report prospective, multicenter results from the Hydrocephalus Clinical Research Network (HCRN) to provide the most accurate determination of morbidity, complication incidence, and efficacy of ETV in children and to determine if intraoperative predictors of ETV success add substantially to preoperative predictors. METHODS All children undergoing a first ETV (without choroid plexus cauterization) at 1 of 7 HCRN centers up to June 2013 were included in the study and followed up for a minimum of 18 months. Data, including detailed intraoperative data, were prospectively collected as part of the HCRN's Core Data Project and included details of patient characteristics, ETV failure (need for repeat hydrocephalus surgery), and, in a subset of patients, postoperative complications up to the time of discharge. RESULTS Three hundred thirty-six eligible children underwent initial ETV, 18.8% of whom had undergone shunt placement prior to the ETV. The median age at ETV was 6.9 years (IQR 1.7-12.6), with 15.2% of the study cohort younger than 12 months of age. The most common etiologies were aqueductal stenosis (24.8%) and midbrain or tectal lesions (21.2%). Visible forniceal injury (16.6%) was more common than previously reported, whereas severe bleeding (1.8%), thalamic contusion (1.8%), venous injury (1.5%), hypothalamic contusion (1.5%), and major arterial injury (0.3%) were rare. The most common postoperative complications were CSF leak (4.4%), hyponatremia (3.9%), and pseudomeningocele (3.9%). New neurological deficit occurred in 1.5% cases, with 0.5% being permanent. One hundred forty-one patients had documented failure of their ETV requiring repeat hydrocephalus surgery during follow-up, 117 of them during the first 6 months postprocedure. Kaplan-Meier rates of 30-day, 90-day, 6-month, 1-year, and 2-year failure-free survival were 73.7%, 66.7%, 64.8%, 61.7%, and 57.8%, respectively. According to multivariate modeling, the preoperative ETV Success Score (ETVSS) was associated with ETV success (p < 0.001), as was the intraoperative ability to visualize a "naked" basilar artery (p = 0.023). CONCLUSIONS The authors' documented experience represents the most detailed account of ETV results in North America and provides the most accurate picture to date of ETV success and complications, based on contemporaneously collected prospective data. Serious complications with ETV are low. In addition to the ETVSS, visualization of a naked basilar artery is predictive of ETV success.
Collapse
Affiliation(s)
| | | | | | | | - D Douglas Cochrane
- BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
| | - James M Drake
- Hospital for Sick Children, University of Toronto, Ontario
| | | | | | | | | | | | | | | | | |
Collapse
|
45
|
McEvoy SD, Lee A, Poliakov A, Friedman S, Shaw D, Browd SR, Ellenbogen RG, Ojemann JG, Mac Donald CL. Longitudinal cerebellar diffusion tensor imaging changes in posterior fossa syndrome. Neuroimage Clin 2016; 12:582-590. [PMID: 27689022 PMCID: PMC5031477 DOI: 10.1016/j.nicl.2016.09.007] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/20/2016] [Revised: 09/06/2016] [Accepted: 09/07/2016] [Indexed: 11/30/2022]
Abstract
Posterior fossa syndrome is a severe transient loss of language that frequently complicates resection of tumors of the cerebellum. The associated pathophysiology and relevant anatomy to this language deficit remains controversial. We performed a retrospective analysis of all cerebellar tumor resections at Seattle Children's Hospital from 2010 to 2015. Diffusion tensor imaging was performed on each of the patients as part of their clinical scan. Patients included in the study were divided into groups based on language functioning following resection: intact (N = 19), mild deficit (N = 19), and posterior fossa syndrome (N = 9). Patients with posterior fossa syndrome showed white matter changes evidenced by reductions in fractional anisotropy in the left and right superior cerebellar peduncle following resection, and these changes were still evident 1-year after surgery. These changes were greater in the superior cerebellar peduncle than elsewhere in the cerebellum. Prior to surgery, posterior fossa patients did not show changes in fractional anisotropy however differences were observed in mean and radial diffusivity measures in comparison to other groups which may provide a radiographic marker of those at greatest risk of developing post-operative language loss.
Collapse
Key Words
- AD, axial diffusivity
- AP, anterior-posterior
- CBW, cerebellar white matter
- CTC, cerebellar-thalamic-cortical
- Cerebellar mutism syndrome (CMS)
- Diffusion tensor imaging
- FA, fractional anisotropy
- KW, kruskal-wallis
- MCP, middle cerebellar peduncle
- MD, mean diffusivity
- MPRAGE, Magnetization Prepared Rapid Acquisition Gradient Echo
- PFS, posterior fossa syndrome
- Posterior fossa syndrome (PFS)
- RD, radial diffusivity
- RESTORE, Robust Estimation of Tensors by Outlier Rejection
- SCP, superior cerebellar peduncle
- SWI, Susceptibility weighted imaging
- TE, echo time
- TORTOISE, Tolerably Obsessive Registration and Tensor Optimization Indolent Software Ensemble
- TR, relaxation time
- Tumor
Collapse
Affiliation(s)
- Sean D McEvoy
- University of Washington, Department of Neurological Surgery, 325 Ninth Avenue, Seattle, WA 98104-2499, USA
| | - Amy Lee
- University of Washington, Department of Neurological Surgery, 325 Ninth Avenue, Seattle, WA 98104-2499, USA; Seattle Children's Hospital, Division of Neurosurgery, 4800 Sand Point Way NE, Seattle, WA 98105, USA
| | - Andrew Poliakov
- Seattle Children's Hospital, Division of Radiology, 4800 Sand Point Way NE, Seattle, WA 98105, USA
| | - Seth Friedman
- Seattle Children's Hospital, Division of Radiology, 4800 Sand Point Way NE, Seattle, WA 98105, USA
| | - Dennis Shaw
- Seattle Children's Hospital, Division of Radiology, 4800 Sand Point Way NE, Seattle, WA 98105, USA
| | - Samuel R Browd
- University of Washington, Department of Neurological Surgery, 325 Ninth Avenue, Seattle, WA 98104-2499, USA; Seattle Children's Hospital, Division of Neurosurgery, 4800 Sand Point Way NE, Seattle, WA 98105, USA
| | - Richard G Ellenbogen
- University of Washington, Department of Neurological Surgery, 325 Ninth Avenue, Seattle, WA 98104-2499, USA; Seattle Children's Hospital, Division of Neurosurgery, 4800 Sand Point Way NE, Seattle, WA 98105, USA
| | - Jeffrey G Ojemann
- University of Washington, Department of Neurological Surgery, 325 Ninth Avenue, Seattle, WA 98104-2499, USA; Seattle Children's Hospital, Division of Neurosurgery, 4800 Sand Point Way NE, Seattle, WA 98105, USA
| | - Christine L Mac Donald
- University of Washington, Department of Neurological Surgery, 325 Ninth Avenue, Seattle, WA 98104-2499, USA
| |
Collapse
|
46
|
Venkataraman P, Browd SR, Lutz BR. A physical framework for implementing virtual models of intracranial pressure and cerebrospinal fluid dynamics in hydrocephalus shunt testing. J Neurosurg Pediatr 2016; 18:296-305. [PMID: 27203135 DOI: 10.3171/2016.2.peds15478] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE The surgical placement of a shunt designed to resolve the brain's impaired ability to drain excess CSF is one of the most common treatments for hydrocephalus. The use of a dynamic testing platform is an important part of shunt testing that can faithfully reproduce the physiological environment of the implanted shunts. METHODS A simulation-based framework that serves as a proof of concept for enabling the application of virtual intracranial pressure (ICP) and CSF models to a physical shunt-testing system was engineered. This was achieved by designing hardware and software that enabled the application of dynamic model-driven inlet and outlet pressures to a shunt and the subsequent measurement of the resulting drainage rate. RESULTS A set of common physiological scenarios was simulated, including oscillations in ICP due to respiratory and cardiac cycles, changes in baseline ICP due to changes in patient posture, and transient ICP spikes caused by activities such as exercise, coughing, sneezing, and the Valsalva maneuver. The behavior of the Strata valve under a few of these physiological conditions is also demonstrated. CONCLUSIONS Testing shunts with dynamic ICP and CSF simulations can facilitate the optimization of shunts to be more failure resistant and better suited to patient physiology.
Collapse
Affiliation(s)
| | - Samuel R Browd
- Division of Pediatric Neurosurgery, Seattle Children's Hospital, Seattle, Washington
| | - Barry R Lutz
- Department of Bioengineering, University of Washington, Seattle; and
| |
Collapse
|
47
|
Hanak BW, Ross EF, Harris CA, Browd SR, Shain W. Toward a better understanding of the cellular basis for cerebrospinal fluid shunt obstruction: report on the construction of a bank of explanted hydrocephalus devices. J Neurosurg Pediatr 2016; 18:213-23. [PMID: 27035548 PMCID: PMC5915300 DOI: 10.3171/2016.2.peds15531] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Shunt obstruction by cells and/or tissue is the most common cause of shunt failure. Ventricular catheter obstruction alone accounts for more than 50% of shunt failures in pediatric patients. The authors sought to systematically collect explanted ventricular catheters from the Seattle Children's Hospital with a focus on elucidating the cellular mechanisms underlying obstruction. METHODS In the operating room, explanted hardware was placed in 4% paraformaldehyde. Weekly, samples were transferred to buffer solution and stored at 4°C. After consent was obtained for their use, catheters were labeled using cell-specific markers for astrocytes (glial fibrillary acidic protein), microglia (ionized calcium-binding adapter molecule 1), and choroid plexus (transthyretin) in conjunction with a nuclear stain (Hoechst). Catheters were mounted in custom polycarbonate imaging chambers. Three-dimensional, multispectral, spinning-disk confocal microscopy was used to image catheter cerebrospinal fluid-intake holes (10× objective, 499.2-μm-thick z-stack, 2.4-μm step size, Olympus IX81 inverted microscope with motorized stage and charge-coupled device camera). Values are reported as the mean ± standard error of the mean and were compared using a 2-tailed Mann-Whitney U-test. Significance was defined at p < 0.05. RESULTS Thirty-six ventricular catheters have been imaged to date, resulting in the following observations: 1) Astrocytes and microglia are the dominant cell types bound directly to catheter surfaces; 2) cellular binding to catheters is ubiquitous even if no grossly visible tissue is apparent; and 3) immunohistochemical techniques are of limited utility when a catheter has been exposed to Bugbee wire electrocautery. Statistical analysis of 24 catheters was performed, after excluding 7 catheters exposed to Bugbee wire cautery, 3 that were poorly fixed, and 2 that demonstrated pronounced autofluorescence. This analysis revealed that catheters with a microglia-dominant cellular response tended to be implanted for shorter durations (24.7 ± 6.7 days) than those with an astrocyte-dominant response (1183 ± 642 days; p = 0.027). CONCLUSIONS Ventricular catheter occlusion remains a significant source of shunt morbidity in the pediatric population, and given their ability to intimately associate with catheter surfaces, astrocytes and microglia appear to be critical to this pathophysiology. Microglia tend to be the dominant cell type on catheters implanted for less than 2 months, while astrocytes tend to be the most prevalent cell type on catheters implanted for longer time courses and are noted to serve as an interface for the secondary attachment of ependymal cells and choroid plexus.
Collapse
Affiliation(s)
- Brian W. Hanak
- Center for Integrative Brain Research, Seattle Children’s Research Institute,Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - Emily F. Ross
- Center for Integrative Brain Research, Seattle Children’s Research Institute
| | - Carolyn A. Harris
- Department of Neurosurgery, Wayne State University, Detroit, Michigan
| | - Samuel R. Browd
- Center for Integrative Brain Research, Seattle Children’s Research Institute,Department of Neurological Surgery, University of Washington, Seattle, Washington
| | - William Shain
- Center for Integrative Brain Research, Seattle Children’s Research Institute,Department of Neurological Surgery, University of Washington, Seattle, Washington
| |
Collapse
|
48
|
Leonard CM, Lombardino LJ, Mercado LR, Browd SR, Breier JI, Agee OF. Cerebral Asymmetry and Cognitive Development in Children: A Magnetic Resonance Imaging Study. Psychol Sci 2016. [DOI: 10.1111/j.1467-9280.1996.tb00335.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Phonemic awareness, the ability to abstract and manipulate auditory symbols, is a distinguishing human characteristic Neurobiological specializations in the left hemisphere and cultural exposure to language interact to shape development of this ability Modern imaging techniques now permit investigation of the interaction of these forces In this initial cross-sectional study, we found evidence for a shift from neurobiological to cultural regulation In young children, aged 5 to 9, anatomical asymmetry of the auditory association cortex predicted phonemic awareness In older children, the relationship disappeared, as all children became skilled readers The findings suggest that children with different patterns of cognitive strengths and weaknesses may have different spatiotemporal patterns of cortical development
Collapse
|
49
|
Kestle JRW, Holubkov R, Douglas Cochrane D, Kulkarni AV, Limbrick DD, Luerssen TG, Jerry Oakes W, Riva-Cambrin J, Rozzelle C, Simon TD, Walker ML, Wellons JC, Browd SR, Drake JM, Shannon CN, Tamber MS, Whitehead WE. A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection. J Neurosurg Pediatr 2016; 17:391-6. [PMID: 26684763 DOI: 10.3171/2015.8.peds15253] [Citation(s) in RCA: 83] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECT In a previous report by the same research group (Kestle et al., 2011), compliance with an 11-step protocol was shown to reduce CSF shunt infection at Hydrocephalus Clinical Research Network (HCRN) centers (from 8.7% to 5.7%). Antibiotic-impregnated catheters (AICs) were not part of the protocol but were used off protocol by some surgeons. The authors therefore began using a new protocol that included AICs in an effort to reduce the infection rate further. METHODS The new protocol was implemented at HCRN centers on January 1, 2012, for all shunt procedures (excluding external ventricular drains [EVDs], ventricular reservoirs, and subgaleal shunts). Procedures performed up to September 30, 2013, were included (21 months). Compliance with the protocol and outcome events up to March 30, 2014, were recorded. The definition of infection was unchanged from the authors' previous report. RESULTS A total of 1935 procedures were performed on 1670 patients at 8 HCRN centers. The overall infection rate was 6.0% (95% CI 5.1%-7.2%). Procedure-specific infection rates varied (insertion 5.0%, revision 5.4%, insertion after EVD 8.3%, and insertion after treatment of infection 12.6%). Full compliance with the protocol occurred in 77% of procedures. The infection rate was 5.0% after compliant procedures and 8.7% after noncompliant procedures (p = 0.005). The infection rate when using this new protocol (6.0%, 95% CI 5.1%-7.2%) was similar to the infection rate observed using the authors' old protocol (5.7%, 95% CI 4.6%-7.0%). CONCLUSIONS CSF shunt procedures performed in compliance with a new infection prevention protocol at HCRN centers had a lower infection rate than noncompliant procedures. Implementation of the new protocol (including AICs) was associated with a 6.0% infection rate, similar to the infection rate of 5.7% from the authors' previously reported protocol. Based on the current data, the role of AICs compared with other infection prevention measures is unclear.
Collapse
Affiliation(s)
- John R W Kestle
- Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Richard Holubkov
- Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - D Douglas Cochrane
- Division of Pediatric Neurosurgery, British Columbia Children's Hospital, Vancouver, British Columbia
| | - Abhaya V Kulkarni
- Division of Neurosurgery, Hospital for Sick Children, Toronto, Ontario, Canada
| | - David D Limbrick
- Department of Neurosurgery, St. Louis Children's Hospital, St. Louis, Missouri
| | - Thomas G Luerssen
- Department of Neurosurgery, Texas Children's Hospital, Houston, Texas
| | - W Jerry Oakes
- Section of Pediatric Neurosurgery, Children's Hospital of Alabama, Birmingham, Alabama
| | - Jay Riva-Cambrin
- Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Curtis Rozzelle
- Section of Pediatric Neurosurgery, Children's Hospital of Alabama, Birmingham, Alabama
| | - Tamara D Simon
- Department of Pediatrics, Division of Hospital Medicine, Seattle Children's Hospital, Seattle, Washington
| | - Marion L Walker
- Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - John C Wellons
- Department of Neurosurgery, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee; and
| | - Samuel R Browd
- Department of Pediatrics, Division of Hospital Medicine, Seattle Children's Hospital, Seattle, Washington
| | - James M Drake
- Division of Neurosurgery, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Chevis N Shannon
- Department of Neurosurgery, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee; and
| | - Mandeep S Tamber
- Department of Neurosurgery, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania
| | | | | |
Collapse
|
50
|
Riva-Cambrin J, Kestle JRW, Holubkov R, Butler J, Kulkarni AV, Drake J, Whitehead WE, Wellons JC, Shannon CN, Tamber MS, Limbrick DD, Rozzelle C, Browd SR, Simon TD. Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study. J Neurosurg Pediatr 2016; 17:382-90. [PMID: 26636251 DOI: 10.3171/2015.6.peds14670] [Citation(s) in RCA: 153] [Impact Index Per Article: 19.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECT The rate of CSF shunt failure remains unacceptably high. The Hydrocephalus Clinical Research Network (HCRN) conducted a comprehensive prospective observational study of hydrocephalus management, the aim of which was to isolate specific risk factors for shunt failure. METHODS The study followed all first-time shunt insertions in children younger than 19 years at 6 HCRN centers. The HCRN Investigator Committee selected, a priori, 21 variables to be examined, including clinical, radiographic, and shunt design variables. Shunt failure was defined as shunt revision, subsequent endoscopic third ventriculostomy, or shunt infection. Important a priori-defined risk factors as well as those significant in univariate analyses were then tested for independence using multivariate Cox proportional hazard modeling. RESULTS A total of 1036 children underwent initial CSF shunt placement between April 2008 and December 2011. Of these, 344 patients experienced shunt failure, including 265 malfunctions and 79 infections. The mean and median length of follow-up for the entire cohort was 400 days and 264 days, respectively. The Cox model found that age younger than 6 months at first shunt placement (HR 1.6 [95% CI 1.1-2.1]), a cardiac comorbidity (HR 1.4 [95% CI 1.0-2.1]), and endoscopic placement (HR 1.9 [95% CI 1.2-2.9]) were independently associated with reduced shunt survival. The following had no independent associations with shunt survival: etiology, payer, center, valve design, valve programmability, the use of ultrasound or stereotactic guidance, and surgeon experience and volume. CONCLUSIONS This is the largest prospective study reported on children with CSF shunts for hydrocephalus. It confirms that a young age and the use of the endoscope are risk factors for first shunt failure and that valve type has no impact. A new risk factor-an existing cardiac comorbidity-was also associated with shunt failure.
Collapse
Affiliation(s)
- Jay Riva-Cambrin
- Division of Pediatric Neurosurgery, Department of Neurosurgery, Primary Children's Hospital, University of Utah
| | - John R W Kestle
- Division of Pediatric Neurosurgery, Department of Neurosurgery, Primary Children's Hospital, University of Utah
| | - Richard Holubkov
- Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Jerry Butler
- Department of Pediatrics, University of Utah, Salt Lake City, Utah
| | - Abhaya V Kulkarni
- Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - James Drake
- Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Ontario, Canada
| | - William E Whitehead
- Division of Pediatric Neurosurgery, Texas Children's Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston, Texas
| | - John C Wellons
- Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Chevis N Shannon
- Department of Neurosurgery, Vanderbilt University, Nashville, Tennessee
| | - Mandeep S Tamber
- Division of Pediatric Neurosurgery, University of Pittsburgh, Pennsylvania
| | - David D Limbrick
- Division of Pediatric Neurosurgery, Washington University, St. Louis, Missouri
| | - Curtis Rozzelle
- Section of Pediatric Neurosurgery, Children's Hospital of Alabama, Division of Neurosurgery, University of Alabama-Birmingham, Alabama; and
| | | | - Tamara D Simon
- Pediatrics, University of Washington/Seattle Children's Hospital, Seattle, Washington
| | | |
Collapse
|